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GENERAL INTRODUCTION 
Principles and History of Affinity Chromatography 
The purification and determination of biological macro-
molecules is an area which has long been of interest. This 
has resulted in the development of a number of separation 
techniques for such compounds as proteins and nucleic acids. 
Most of these methods are based on physiochemical differences 
in the molecules being separated, including their size, shape, 
and charge. Examples of such techniques are electrophoresis, 
ion-exchange chromatography, and size exclusion chromatography 
(1-3). 
In biomacromolecular separations, the molecule of 
interest may only occur in small amounts or in the presence of 
a large number of similar compounds. As a result, a multistep 
procedure based on several different techniques may be needed 
to obtain a good separation. This approach not only requires 
a great deal of time and effort, but may also give the desired 
compound in only a low yield (4,5). 
One alternative approach is to use affinity chromatog­
raphy. Affinity chromatography may be defined as a chromato­
graphic technique based on the selective, reversible inter­
actions of biologically active molecules (4). In other words, 
it is based on a functional property, the ability of biolog­
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ical molecules to bind selectively with other molecules. This 
type of interaction is characteristic of many biological 
systems, such as the binding of enzymes with substrates, anti­
bodies with antigens, and hormones with hormone receptors (6). 
In affinity chromatography, these interactions are used 
by attaching a molecule able to selectively, bind the analyte, 
or molecule of interest, to a solid support. This immobilized 
molecule is called the affinity ligand. Although the ligand 
is usually of biological origin, compounds including synthetic 
dyes (7), metal chelates (8), thiol groups (9), and apolar 
groups (10) have also been used. 
Once the ligand has been immobilized, the support is 
packed in a column and used in a separation scheme such as 
shown in Figure 1. First, sample is applied to the column 
under conditions which allow the analyte to bind to ligand. 
This is known as the adsorption step. Since, ideally, the 
ligand binds only with the analyte, other components of the 
sample are eluted from the column and appear in the non-
retained peak. 
The analyte is eluted by changing the mobile phase com­
position to dissociate the analyte-ligand complex. This may 
be done through nonspecific methods which cause conforma­
tional changes in the analyte or ligand. These methods 
include changing the pH, ionic strength, or organic solvent 
gure 1. Separation scheme for affinity chromatography 
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content of the mobile phase. The analyte can also be eluted 
by using a technique known as biospecific elution. In this 
case, a compound is added to the mobile phase that competes 
for active sites on the analyte or ligand, forcing the analyte 
off the column by mass action (11). For example, enzyme 
retained on an immobilized inhibitor column may be eluted by 
adding free inhibitor to the mobile phase. After the analyte 
has been eluted by one of these methods, the mobile phase is 
changed back to its original composition, the column regener­
ated, and the entire process repeated with the next sample. 
Based on this technique, a large number of analytes have 
been purified and studied. These have included enzymes, anti­
bodies, and nucleic acids, as well as cells and viruses 
(4,5,11). In many cases, the high selectivity of affinity 
chromatography allows these separations to be performed in 
only one or two steps, with typical purifications of a 
hundred- to thousand-fold (4,5). In work with hormone 
receptors, a purification in excess of 500,000-fold has even 
been reported (4). 
The first reported use of affinity chromatography was in 
1910, when Starkenstein used insoluble starch to purify ot-
amylase (12). In 1924, it was proposed that such a technique, 
in which analyte binds to a "fixed partner", would be useful 
as a general method for the separation of active biological 
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compounds (13). However, the first use of immobilized ligands 
was not reported until 1951, when Campbell et al. used anti­
gens attached to a solid support for the purification of 
antibodies (14). Affinity chromatography was soon used to 
purify a number of other compounds, including tyrosinase (15), 
flavokinase (16), and avidin (17). 
Despite this work, the technique did not enjoy widespread 
use until the 1960s. Several important breakthroughs 
occurred at this time. One was the introduction of better 
affinity chromatographic supports, such as beaded agarose 
(18). Another was the development of the cyanogen bromide 
method (19), a general technique for the coupling of proteins 
and other ligands to these supports through primary amine 
groups. Both developments were used in 1968 by Cuatrecasas et 
al. to produce what are considered the first modern affinity 
chromatographic separations (20). 
Affinity chromatography has since become a popular tool 
for biochemical separations, with its use being reported in 
more then 3,500 papers over the past 19 years. During this 
time, agarose and other soft gels have been the supports most 
commonly used. These nonrigid supports have limited most of 
the reported applications to the use of low flowrates and 
pressures, resulting in typically long analysis times (11,21). 
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More rapid separations were made possible by the devel­
opment of diol-bonded silica in 1976 by Regnier and Noel (22). 
Diol-bonded silica is a rigid, uniform support material. This 
makes it more chromatographically efficient than agarose and 
allows it to be used at higher flowrates. Also, it does not 
adsorb most proteins, unlike normal silica (23), and yet can 
be easily modified for ligand attachment. These properties 
make it an almost ideal affinity chromatographic support. The 
potential of diol-bonded silica in affinity chromatography was 
demonstrated in 1978 by Ohlson et al., who used it to obtain 
several affinity separations with analysis times of only 5 min 
(24). This was the beginning of the technique known as high-
performance affinity chromatography (HPAC). 
Because HPAC combines the selectivity of affinity chroma­
tography with the speed of high-performance liquid chromatog­
raphy (HPLC), a great deal of interest has been expressed in 
developing HPAC as a viable analytical technique. Although 
still an area of active research, a number of analytical 
applications using HPAC have already been developed. These 
include the profiling of urine samples (25), the measurement 
of immunoglobulins in cerebrospinal fluid (26) and serum (27), 
and the development of reusable immunoassays (28). In some 
cases, such separations are possible in as little as one to 
three minutes (21,27). This work will examine some of the 
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practical and fundamental aspects of using HPAC in analytical 
applications, but most of the principles discussed will apply 
to low-performance affinity chromatography as well. 
Review of Previous Work 
In affinity chromatography, a number of factors must 
be considered in obtaining good separations. These include 
choosing a suitable ligand and immobilization method, 
selecting the correct mobile phase conditions for analyte 
adsorption, and determining how to elute analyte from the 
column without irreversibly damaging the immobilized ligand 
(5,11,29). Another factor which can be important is the 
amount of time allowed for adsorption. Failure to consider 
this can result in a significant amount of analyte eluting in 
the nonretained peak. This occurs due to what is known as the 
split-peak effect. 
The split-peak effect occurs when injection of even a 
small amount of pure analyte results in two fractions; a non-
retained peak and a strongly-retained peak. This is believed 
to be a result of the kinetic nature of the chromatographic 
process and is characterized by a change in the relative size 
of the nonretained peak with flowrate and/or column size. 
The theoretical basis of this effect dates back to 1955, 
when it was shown by Giddings and Eyring that a molecule 
9 
undergoing simple first-order adsorption on a column has a 
* k t probability e of eluting without being retained, where k 
is the first-order adsorption rate constant and t is the void 
time of the column (30). It was later demonstrated by DeLisi 
et al. in computer simulations that this effect can also be 
produced by slow mass transfer processes within the column, 
such as diffusion of the analyte into and out of the pores of 
the support (31). 
The earliest recognized report of this phenomenon was 
made by Cuatrecasas, Wilchek, and Anfinsen in 1968 (20), 
the same work in which the first modern affinity chromato­
graphic separations were presented. This effect was seen when 
they attempted to purify staphylococcal nuclease on an 
immobilized inhibitor column. In this experiment, it was 
found that a small amount of nuclease sometimes appeared in 
the nonretained fraction. Although partly related to the 
sample concentration used, the amount of nonretained nuclease 
was also found to be flowrate dependent, with nonretained 
nuclease tending to appear when fast flowrates were used (20). 
The time dependence of analyte adsorption was studied in 
more detail by Lowe et al. in 1974 (32). In this work, the 
binding of lactate dehydrogenase and glycerokinase to an AMP-
Sepharose column was examined as a function of adsorption 
time. Although the column had the same capacity for both 
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enzymes, significant differences were noted in the amount of 
each enzyme that bound to the column as the adsorption time 
was varied. For the lactate dehydrogenase, essentially all of 
the enzyme was found to bind over adsorption times of 1, 20, 
and 67 hours. Glycerokinase, however, gave nonretained frac­
tions ranging from 41 to 74% under the same time and sample 
size conditions, with the amount of nonretained glycerokinase 
increasing as the adsorption time decreased. It was also 
noted that the time required for adsorption at a given flow-
rate could be varied by changing the column size, in that even 
nonretained lactate dehydrogenase could be obtained if suffi­
ciently small columns were used. In explaining these effects, 
it was suggested that they were somehow related to the rate of 
interaction of the enzymes with the immobilized ligand (32). 
Since the presence of nonretained analyte is undesirable 
in any type of chromatographic separation, it was not long 
after this effect was observed that a number of methods were 
proposed for dealing with it. One suggested technique was to 
simply use low flowrates in order to allow sufficient time for 
analyte adsorption (29,33). Another was to stop the flow of 
analyte through the column during the adsorption step (29,32), 
again resulting in an increase in the adsorption time. 
Although these techniques were potentially useful in reducing 
the split-peak effect, they did so at the cost of increasing 
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the overall separation time. Despite the fact that a better 
understanding of this effect could have allowed the extent of 
this increase to be minimized, little further work was done 
in this area for some time. 
It was shortly after the Introduction of HPAC that a 
renewed interest in this effect appeared. The first report 
of the split-peak effect in HPAC was in 1980 by Sportsman and 
Wilson, where it was observed in both the retention of immuno­
globulin G (IgG) on immobilized anti-IgG antibodies and in the 
binding of insulin to a similar anti-insulin support (34). 
The effect was soon reported in a number of other HPAC 
systems. These included the adsorption of trypsin and a-
chymotrypsin to immobilized soybean trypsin Inhibitor (35,36), 
the binding of leukocyte A Interferon to immobilized anti-
interferon antibodies (37), the adsorption of acetylcholin­
esterase to immobilized procainamide (38), and the binding of 
glusose oxidase antibody conjugates to antigen previously 
adsorbed on an affinity column (28). 
Since the goal of HPAC is to provide faster separations 
than are obtained with low-performance affinity chroma­
tography, the guidelines previously used in dealing with the 
split-peak effect were no longer adequate. Instead, a better 
understanding of the relationship between retention and the 
adsorption time was needed, allowing the amount of analyte 
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retained in a given amount of time to be optimized. One study 
examining this effect more closely was the work of Roy et al. 
(37). The goal of this study was to develop an HPAC system 
for the fast purification of recombinant interferon. One of 
the factors considered in the design of this system was the 
amount of interferon retained as a function of flowrate. This 
was studied by applying known amounts of analyte to anti-
interferon columns at various flowrates. The amount of 
retained interferon was then determined and plotted as a 
function of flowrate and sample load. From these plots, it 
was possible to determine what flowrate conditions were needed 
to produce a given degree of analyte adsorption at a partic­
ular load. Although an entirely empirical approach, this 
method was effective in quantitativly dealing with the split-
peak effect (37). 
A more fundamental approach was suggested by the work of 
Sportsman et al. (34,39). In this case, the split-peak effect 
was related directly to the reactions involved in analyte 
adsorption. This was first done by describing the adsorption 
process in terms of an equilibrium between the bound and free 
analyte (34). This system was chosen since the ratio of the 
bound to free analyte (b/f) obtained on immunoaffinity columns 
was found to vary with sample size in a manner similar to that 
seen in immunoassays, which are usually described by an equi­
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librium model. Based on this model, plots of b/f vs. sample 
size were used to give an apparent equilibrium constant, K*, 
for each of the systems studied. Although it was predicted 
that such plots should give a linear response, significant 
curvature was actually seen. It was suggested that this 
curvature was due to antibody heterogeneity, but the 
additional fact that K' varied with flowrate indicated that 
this model did not adequately describe the split-peak effect 
for the systems studied (34). 
A different model was used in the second series of 
experiments. In this case, analyte adsorption was described 
in terms of a second-order reversible rate expression (39). 
This model was then used to study the binding of insulin to an 
immunoaffinity column by measuring the amount of nonretained 
insulin as a function of flowrate. The data were then plotted 
according to the rate expression for the model, using the 
column void time as the time of reaction. To obtain kinetic 
data from this plot, it was also necessary to determine the 
value of the equilibrium binding constant. This approach did 
give an adsorption rate constant comparable to that obtained 
in batch kinetic studies, but the plots again showed signif­
icant deviations from the predicted response (39). Although 
neither this nor the previous model appeared to adequately 
describe the data, this work did suggest that a more funda-
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mental description of the split-peak effect might be possible. 
This work also suggested that the effect might be useful in 
the determination of such physical parameters as adsorption 
rate constants. 
Statement of the Problem 
It has already been shown that the split-peak effect can 
be an important consideration in the use of affinity 
separations. It has also been shown that a good quantitative 
description of this effect has not yet been developed. One 
goal of this work, then, was to study the split-peak effect 
and to develop a theoretical model by which it could be 
quantitated or measured. Once developed, this model was 
tested by using it to characterize the split-peak behavior of 
IgG on protein A affinity columns, as described in Section I. 
Another goal of this work was to explore any possible 
analytical applications of the split-peak effect and the model 
used to describe it. One such application is the optimization 
of analyte adsorption. This is illustrated in Section II, 
where the equations developed in this work are used in the 
design of an HPAC system for the determination of two serum 
proteins. Two other applications, the comparison of the 
kinetic properties of affinity supports and the determination 
of chromatographic rate constants, are discussed in Section I. 
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Finally, some fundamental aspects of the split-peak 
effect are also considered. One of these is the effect of 
nonlinear elution conditions on the amount of nonretained 
analyte. This was examined through the use of computer 
simulations. The results of this study are presented in 
Section III. 
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THEORETICAL DESCRIPTION OF THE SPLIT-PEAK EFFECT 
Chromatographic Model 
To obtain a method for quantitating the split-peak 
effect, it was first necessary to derive an equation that 
could be used to describe it. This was accomplished using the 
same chromatographic model as presented earlier (31,40-43). 
In this model, the column is divided into three distinct 
phases. The first is the stationary phase, which contains the 
immobilized ligand or analyte adsorption sites. The second is 
the mobile phase directly in contact with the ligand. This 
includes any eluent within the pores of the support or on its 
surface and is referred to as the stagnant mobile phase. The 
volume of this phase is given by Vp, the pore volume. The 
third phase is the eluent which freely flows through the 
column. This includes any mobile phase located outside of the 
pores of the support and is referred to as the flowing mobile 
phase. The volume of this phase is given by Vg, the elution 
volume of a solute totally excluded from the pores. 
As analyte E travels through the column in the flowing 
mobile phase, it is viewed in this model as undergoing the 
following reactions leading to its adsorption: 
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k3 
Ep + L ? ( 2 )  
In these reactions. Eg and Ep represent the analyte in the 
flowing mobile phase and stagnant mobile phase, respectively, 
and L is the immobilized ligand. Mass transfer of E between 
the flowing and stagnant mobile phases is described by the 
first-order rate constants and The binding of E with 
L is described by the second-order adsorption and first-order 
desorption rate constants, kg and k^g. 
The values of k^ and k_^ are related to the excluded 
volume and pore volume, Vg and Vp, by 
where m, and m^ are the moles of E_ and E„ at equilibrium 
^poo «-eœ P G 
and is the mass transfer equilibrium constant. Also, kg 
and k_3 are related to Kg, the equilibrium constant for the 
binding of analyte to ligand, by 
where [] represents the concentration of the given species in 
the stagnant mobile phase. 
Ki = 1^  ^_2p_  ^"'Epco 
k-1 Ve mEeoo 
(3) 
kg [Ep-L] 
(4) 
k_3 [Ep] [L] 
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Derivation of the Split-Peak Equation 
The split-peak effect was described using a special case 
of the system given in Equations 1 and 2. In this special 
case, it is assumed that linear elution conditions are present 
(i.e., [L] >> [Ep]) and that E adsorbs irreversibly on the 
time scale of the experiment (i.e., k_g = 0 or the binding of 
E to L is sufficiently strong to allow the nonretained and 
retained peaks to be resolved from one another). The net 
result of these assumptions is that Equation 2 reduces to the 
simple first-order reaction 
ko [L] 
Ep > Ep-L (5) 
where kg [L] is the apparent first-order adsorption rate 
constant. 
Based on this system, the relative amount of analyte in 
the nonretained peak can be obtained using procedures similar 
to those given in References 31 and 40 through 43. This is 
accomplished by determining the distribution of analyte in 
the column as a function of time. To do this, the location of 
analyte in the column is described by the variable x, where 
X = 0 at the column outlet and x = h, the column length, at 
its inlet. Time is described by the variable t, where t = 0 
at the time of injection. 
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The distribution of analyte in the column is given by the 
functions p(x,t), q(x,t), and r(x,t). These represent the 
probabilities of finding analyte in the flowing mobile phase, 
stagnant mobile phase, and stationary phase, respectively, at 
any given time and column location. 
By using a conservation of mass approach along with the 
reactions given in Equations 1 and 5, the following system of 
partial differential equations are obtained describing the 
change in these probabilities with time and distance along the 
column : 
5p ôp 
— = Ug — - ki p + k_i q (6) 
Ôt ÔX 
ôq 
— = kl p - k_i q - kg [L] q (7) 
èt 
èr 
— = kg [L] q (8) 
ôt 
where Ug is the linear velocity of an excluded, nonretained 
solute and all other parameters are as defined previously. 
To solve the above equations, it is assumed that the 
injection volume of analyte is small vs. the total column 
volume. This allows the initial layer of analyte on the 
column to be viewed as an instantaneous source of analyte, 
which may be described by a Dirac delta function. Using 
this gives the initial conditions for 0 ^  x <. h as being 
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p(x,0) = ô(x - h) (9) 
q(x,0) = 0 (10) 
r(x,0) = 0 (11) 
Since there are no molecules at the inlet of the column once 
the initial layer leaves, the boundary conditions for t > 0 
are 
p(h,t) = 0 (12) 
q(h,t) = 0 (13) 
r(h,t) = 0 (14) 
By integrating Equations 6 through 8 from zero to 
infinity with respect to t and using the initial conditions 
given in Equations 9 through 11, the following results are 
obtained : 
r(x,») = kg [L] J? q(x,t) dt 
= ki Jo p(x,t) dt - k_% Jo q(x,t) dt (15) 
r» f<x> 
Jo q(x,t) dt = ki/(k_i + kg [L]) JO p(x,t) dt (16) 
à fflo 
ue — Jo p(x,t) dt = -o(x - h) - r(x,oo.) 
dx 
=  - 5 ( x  - h) - ki/(l + k_x/k3 [L]) Jo p( x,t) dt (17) 
Letting y = h - x, Laplace transforms can be used to solve 
Equation 17 with the boundary conditions in Equations 12 
through 14 to give 
21 
P» 
Jo Ug p(x,t) dt g-c(h - x) (18) 
r(x,oo) = c e"c(h - x) (19) 
in which c is defined by the expression 
c = (k^/Ug)/(l + k_i/k3 [L]) ( 2 0 )  
Note that Ug p(0,t) is simply the elution profile of the 
analyte and r(x,ao) is the distribution of retained molecules 
in the column. This means that integration of Ug p(0,t) over 
times of zero to infinity will give the total relative amount 
of analyte eluting in the nonretained peak, or the free 
fraction (f). Similarly, integration of r(x,<») over the 
entire length of the column will give the total relative 
amount of retained or bound analyte (b). When this is done, 
the following results are obtained: 
Substituting in the definition of c given in Equation 20 and 
rearranging terms, Equation 21 can be written in the following 
form : 
(21) 
( 2 2 )  
-1 Ug 1 k_i 
In f h k% ki kg [L] 
) (23) 
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Since [L] is defined as the concentration of ligand sites 
in the stagnant mobile phase, it can be related to mi, the 
total moles of ligand in the column, by the expression 
[L] = raL/Vp (24) 
It is also possible from the model to relate Ug to the flow-
rate (F) through the relationship (42) 
ue = F h/Ve (25) 
By substituting these expressions for [L] and Ug into Equation 
23 along with the fact that Vp/Vg = ki/k_i from Equation 3, 
the following result is obtained; 
- 1  1 1  
= F ( + ) (26) 
In f ki Ve kg mi 
The above equation predicts that a plot of -1/ln f vs. F will 
give a straight line with an intercept of zero and a slope 
equal to (1/kl Ve + l/k3 ml). This relationship is what will 
be referred to as the split-peak equation. 
As stated earlier, two experimental conditions must be 
met to apply this equation. One is that linear elution 
conditions are present, or that the relative amount of free 
and bound analyte is independent of sample size. The second 
is that adsorption must be essentially irreversible on the 
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time scale of the experiment, or that the nonretained and 
retained peaks are sufficiently resolved to allow the bound 
and free fractions to be measured independently from one 
another. Another assumption made in the derivation is that 
the injection volume is negligible vs. the total column 
volume, allowing sample input to be represented by a Dirac 
delta function. However, this is not a necessary experimental 
requirement since larger injection volumes may be regarded as 
a series of delta functions, in each of which the same frac­
tion f elutes without retention. 
These are also a number of assumptions made in using this 
particular chromatographic model. One is that the system can 
be described by a single set of rate constants, or by a homo­
geneous system. The possible affect of deviations from this, 
or the presence of column heterogeneity, will be discussed in 
both Sections I and III. The model also assumes that the 
effect of processes other than adsorption or mass transfer 
between the stagnant and flowing mobile phases, such as mass 
transfer of analyte within the flowing mobile phase or 
extracolumn band-broadening, is negligible. The validity of 
this assumption will be discussed in Section III. 
Despite these possible limitations. Equation 26 is useful 
in qualitatively explaining many of the previous observations 
made regarding the split-peak effect. For example, it pre-
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diets an increase in the amount of nonretained analyte with 
flowrate, as seen in earlier studies (20,32,35-37,39). This 
occurs since both f and -1/ln f increase with F. Equation 26 
also predicts an increase in f as the column size decreases, 
as observed by Lowe et al. (32). This is expected since a 
decrease in column size causes a proportional decrease in both 
Vg and mj^. The result is an increase in the slope of Equation 
26 and the flowrate dependence of f. 
Although the model used in this derivation is applicable 
to any type of liquid chromatography involving analyte adsorp­
tion as the retention mechanism, split-peaks are only commonly 
reported in affinity chromatography. A closer examination of 
the parameters in Equation 26 reveals why this is the case. 
One possible reason is that m^^ is often much smaller 
for affinity supports than other chromatographic matrices. 
This is related not only to the column size, but also to its 
surface area and ligand density. Under the same column size 
and support conditions, affinity columns may have between 10-
to 1000-fold fewer ligands than ion-exchange or reversed-phase 
columns. This is due to the larger size of the ligands 
typically used in affinity chromatography. For example, an 
immobilized protein may cover up to 10^ of the surface 
area of the support, while each of the alkyl groups commonly 
used in reversed-phase supports occupy only about 40 per 
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molecule (44). Since the slope of Equation 26 increases as m^ 
decreases, the lower ligand density of affinity columns tends 
to make split-peaks more likely to occur. 
Split-peaks are also more likely to observed as the mass 
transfer rate constant k]^ decreases. In this model, k^ is • 
directly proportional to the diffusion coefficient (D), as 
will be shown in Section I. This makes split-peaks more 
likely to occur when slowly diffusing analytes, such as 
macromolecules, are chromatographed. This takes place since 
k2 may decrease by 10- to 100-fold in going from a small 
solute, with a molecular weight of 100 or less and a diffusion 
coefficient of approximately 10"^ cm^/sec, to analytes such as 
proteins, which have diffusion coefficients of 10~6 to 10~7 
cra2/sec (45). 
Overall, this indicates that the reason why split-peaks 
are not usually observed in most types of liquid chromatog­
raphy is that the split-peak slopes for these techniques 
(i.e., the slope term of Equation 26) are much smaller than 
those usually obtained in affinity chromatgraphy. These 
smaller slopes result in most forms of chromatography having 
only negligible free fractions (i.e, f = 0 ) under normal 
operating conditions. However, it will be shown that split-
peaks can also be observed in areas other than affinity 
chromatography if the proper operating conditions are used. 
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SECTION I. 
STUDIES OF THE IMMOBILIZATION-DEPENDENT ADSORPTION 
KINETICS OF PROTEIN A 
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INTRODUCTION 
It was shown earlier how the equations developed in 
this work agree qualitatively with previous experimental 
observations of the split-peak effect. This makes them useful 
in explaining the split-peak effect and in developing guide­
lines that can be used to minimize it. To be useful for an 
application such as the optimization of analyte adsorption, 
however, it is also necessary that they agree quantitatively 
with the experimental results. To determine whether or not 
this is the case, one purpose of this study was to compare the 
flowrate dependence of adsorption predicted by the model to 
that actually seen with an experimental system. The partic­
ular system used for this was the adsorption of rabbit IgG on 
immobilized protein A. 
Protein A is a 42,000 molecular weight protein from the 
cell walls of Staphylococcus aureus (46,47). It is made up of 
a single polypeptide chain arranged in an elongated structure. 
This structure consists of four immunoglobulin binding sites 
at the N-terminal end and a cell wall binding region at the C-
terminal end (48). Rabbit IgG is a 150,000 molecular weight 
protein (49). It is the most abundant type of antibody in 
rabbit serum (49) and consists of only one known subclass 
(50). Each IgG molecule is made up of four polypeptide 
chains: two identical H or heavy chains, each with a 
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molecular weight of about 50,000, and two identical L or light 
chains, each with a molecular weight of approximately 25,000 
(49). These are joined by disulfide bonds to give a structure 
made up of two antigen binding sites, or regions, and one 
constant, or Fg, region (49). Protein A binds primarily with 
Fg region (50). 
Since it was first described by Verwey in 1940 (51), 
protein A has become a popular biochemical tool. This is due 
to its ability to bind immunoglobulins from several mammalian 
species (50). One use of protein A has been as an affinity 
ligand for the purification and separation of immunoglobulins 
(52,53). Such separations are usually performed by allowing 
immunoglobulins to bind to protein A at a pH of 7.0 to 7.4 and 
later dissociating the resulting complex by going to more 
acidic elution conditions (50). Protein A can also be used as 
an antibody-binding reagent for a number of different immuno-
techniques. One characteristic of protein A that makes it 
especially attractive for this is that it binds primarily with 
the FQ region of antibodies, allowing the adsorbed antibodies 
to retain their antigen-binding activity (50). This makes 
protein A useful as a reagent in indirect immunoassays (52) 
and as an antibody coupling reagent for the preparation of a 
variety of immunoaffinity supports (54). 
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The IgG-protein A system was chosen for this study not 
only for its practical importance, but also due to the fact 
that split-peaks for this system have already been observed. 
For example, in one previous study it was shown that signif­
icant amounts of nonretained human IgG were obtained when 
nonoverloading samples were injected in 6 mm protein A HFAC 
columns (55), while the same system exhibited normal chromato­
graphic behavior when 5 cm columns were used (27). In another 
study, it was observed that the amount of canine immuno­
globulin bound to protein A Sepharose columns could be 
increased by recycling sample through the column (56), in 
effect increasing the analyte adsorption time. 
Besides verifying the equations developed in the previous 
chapter, another goal of this study was to examine the kinetic 
properties of the IgG-protein A system. The use of affinity 
chromatography for the determination of physical parameters, 
such as rate constants and equilibrium constants, is an area 
known as quantitative affinity chromatography. The first 
reported use of this technique was by Andrews et al. in 1973 
(57). In this study, affinity chromatography was used to 
determine the equilibrium constants for the interaction of 
human galactosyltransferase with glucose and N-acetyl-glucos-
amine (57). This technique has since been used to determine 
equilibrium constants for a large number of other systems, as 
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reviewed by Dunn (58) and Chaiken (59). Systems that have 
been studied with this technique include the binding of 
psychoactive drugs to bovine glutamate dehydrogenase (60), the 
interaction of lactate dehydrogenase with the dye Cibacron 
Blue (61), and the binding of immunoglobulin A Fab fragments 
with phosphorylcholine (62). 
Although widely used for the determination of equilibrium 
constants, only a few studies have been reported using 
affinity chromatography for the determination of rate 
constants (35,39,59,63-65). This is typically done by 
relating the kinetics of analyte-ligand interactions to band-
broadening of the analyte peak as it isocratically elutes from 
an affinity column. Even though the theoretical basis for 
this is well-developed (42,43,66-68), the experiments involved 
in these studies are complicated by a number of factors. 
These factors include extracolumn band-broadening (67), 
measurement errors in the statistical moments used to deter­
mine band-broadening (69), and dependence of some theoretical 
terms on the degree of analyte retention (67,70,71). As 
suggested by the work of Sportsman et al. (39) and the 
equations derived in this work, the split-peak effect may 
allow an alternative approach to obtaining affinity rate 
constants, in that it allows the kinetics of the analyte-
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ligand interaction to be related to à more easily measured 
parameter, the peak area. 
In this study, the split-peak effect was used to examine 
the kinetic properties of protein A supports prepared by 
different immobilization methods. Changes in the properties 
of protein A as a result of immobilization have been 
previously noted by Nilsson et al. (72). In this earlier 
study, it was found that protein A immobilized on agarose 
had different binding specificities for rat IgG than found 
with native bacteria-bound protein A. This was seen in that 
the binding strength of immobilized protein A for two 
subclasses of rat IgG was larger than that obtained for native 
protein A, while binding to two other subclasses was not 
affected (72). 
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THEORY 
Equation 26 was used to compare the flowrate dependence 
of analyte adsorption predicted by the model to that actually 
seen with the IgG-protein A system. 
- 1  1 1  
= F ( + ) (26) 
In f Ve kg mj. 
As pointed out previously, this equation predicts that a plot 
of -1/ln f vs. flowrate will give a linear relationship with 
an intercept of zero and a slope equal to (l/k^ Vg + l/kg mi,). 
Note that the first term in the slope, 1/k^ V^, is related to 
diffusion or mass transfer of analyte from the flowing mobile 
phase to the stagnant mobile phase, while the second, l/kg m^, 
is related to analyte adsorption. If diffusion is the rate-
limiting step in retention (i.e., kg [L] >> k^ and k.^), the 
first term dominates. If adsorption is rate-limiting (i.e., 
kg [L] << ki and k_i), the second term dominates. Inter­
mediate cases can also occur. 
One way in which Equation 26 was used in this experiment 
was to compare the kinetic properties of different affinity 
supports. This can be done by comparing the overall slope 
obtained for each support under equivalent operating 
conditions or by performing further experiments to determine 
the values of the individual rate constants. For example. 
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the value of kg can be obtained from the slope of Equation 26 
if values of Vg, m^, and are already known. Vg can be 
determined by measuring the elution volume of a large, 
excluded solute. Breakthrough curves or other means can be 
used to measure m^. 
Two different approaches can be used to estimate k^. In 
the first, split-peak measurements are made under conditions 
in which the term l/kg m^j is negligible, or diffusion is rate-
limiting. Under these conditions. Equation 26.reduces to 
-1 1 
= F ( ) (27) 
In f k^ Vg 
which predicts that a plot of -1/ln f vs. F for a diffusion-
limited system will give a straight line with an intercept of 
zero and a slope of 1/k^ Vg. Thus, k^ can be determined from 
this slope once Vg has been measured. 
One system that may exhibit the split-peak effect under 
diffusion-limited conditions is the adsorption of proteins on 
reversed-phase columns (73). This system would be expected to 
be diffusion-limited since reversed-phase supports typically 
have a large value of m%, due to the small amount of surface 
area required by each ligand, as discussed previously. 
Another possible factor is that kg may be larger for protein-
ligand interactions in reversed-phase chromatography than in a 
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technique such as affinity chromatography. This would be 
expected since affinity ligand-analyte interactions are 
typically very site specific, requiring a particular orienta­
tion of both the analyte and ligand in order for binding to 
occur (29), while protein retention on reversed-phase columns 
involves a less specific mechanism, the adsorption of analyte 
on a large hydrophobic surface (73). 
Equation 27 can be applied to obtain l/k^ Vg for affinity 
columns by making split-peak measurements on reversed-phase 
supports prepared using the same original support material. 
Under equivalent application conditions, both systems would be 
expected to exhibit similar protein mass transfer kinetics. 
Thus, the reversed-phase results can be used to calculate k^ 
for the affinity supports or to provide an estimate of their 
diffusional slope term. 
A second estimate of k^ can be made by measuring the 
band-broadening of the analyte peak under isocratic elution 
conditions. Band-broadening in chromatography is usually 
expressed in terms of H, the plate height, which may be 
defined as follows (74): 
H = cr2/L (28) 
where L is the column length and is the variance of the 
peak expressed in units of column length. 
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Various processes contribute to the width of peaks in 
chromatography. These processes are usually assumed to be 
independent of one another, allowing them to be described by 
separate variance or plate height terms. These terms are then 
added together to give the total plate height, H (74). For an 
adsorption technique such as affinity chromatography, H can be 
represented as the sum of the following terms: 
H = Hgc + Hi + + «sm + % (29) 
In this expression, HQ Q  represents the plate height contri­
bution of extracolumn effects, such as band-broadening within 
the tubing of the system or dispersion caused by the use of 
large sample loops. gives the plate height due to longi­
tudinal diffusion (i.e., diffusion parallel to solvent flow). 
Hj, represents the plate height contribution of mass transfer 
effects in the flowing mobile phase, such as sample dispersion 
caused by the presence of multiple flow paths through the 
column (i.e., eddy diffusion) and nonuniform flow profiles. 
Hsm gives the contribution due to mass transfer between the 
flowing and stagnant mobile phases and gives the plate 
height due to the kinetics of analyte adsorption/desorption 
(74,75). 
One of the main goals of chromatographic theory has been 
to relate these various plate height terras to fundamental 
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properties of the chromatographic system and the column 
operating conditions (74). The results have usually been 
expressed in terms of equations relating plate heights to the 
linear velocity of analyte through the column (u). Examples 
of such equations include those developed by van Deemter et 
al, (76), Giddings (66), and Kennedy and Knox (77). Using the 
same model as presented here, Hethcote and DeLisi have derived 
equations for Hg^ and in the case of affinity chroma­
tography (42,43). Based on these, the following plate height 
expression can be written for the system given in Equations 1 
and 2 (75): 
2 u Vp (1 + Vm k'/Vp)2 2 u k' 
H = Hec + Hm + : + (30) 
k-i Vm (1 + k')^ k_3 (1 + k')? 
where the two linear velocity terms represent the plate height 
contributions due to Hgj, and Hjj, respectively, and k* is the 
capacity factor, a measure of analyte retention. The term 
in this equation is identical to that derived by others (66, 
67,78). The term is also equivalent to previous 
expressions (66,67,71,78), given the fact that the values of 
ki and k_% in this model are really combinations of geometric 
and diffusional factors, as shown by Equation 31. 
60 T p D 
k.i = ki (Vg/Vp) = g (31) 
dp 
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In this relationship, dp is the particle diameter of the 
packing material and Djj is the diffusion coefficient of 
analyte in the bulk mobile phase. The other two parameters, 
f and p, are the tortuosity factor (66) and the restricted-
diffusion factor (71), constants correcting for the slower 
diffusion of solute once within the pores of the support. 
Note in Equation 30 that both the HgjQ and % terms show a 
first-order relationship between the plate height and u, while 
the contributions due to Hgg and HJQ are considered to be 
either small or flowrate independent. It is also important to 
note that is not considered in Equation 30. This is due to 
the fact that longitudinal diffusion in liquid chromatography 
is often insignificant, making this term negligible (74). 
To determine k^ using Equation 30, column conditions are 
adjusted so that analyte is not retained on the column (i.e., 
k' =0), An example of such a system is the elution of 
protein on a column containing diol-bonded silica. Under 
these conditions. Equations 3 and 30 can be combined to yield 
the following expression: 
2 u Vp2 
H = Hec + Hm + (32) 
kl Ve Vm 
which predicts that a plot of H vs. u will give a straight 
line with an intercept of (Hec + H^) and a slope equal to 
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(2 Vp2)/(k2 Vg Vjjj). Thus, from this slope an estimate of 
can be obtained for a given analyte on a particular support. 
Note that this requires that the values of Vg and other 
parameters again be known. Vg is determined as described 
previously and Vm, the elution volume of analyte from the 
column, can be measured in the same experiment used to 
generate the peak height data. Vp is obtained by simply 
calculating the difference between Vg, and Vg. 
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EXPERIMENTAL 
Reagents 
The protein A, rabbit IgG, and sodium cyanoborohydride 
were from Sigma (St. Louis, MO) and were the purest grades 
available. The 1,1•-carbonyldiimidazole (GDI), 1-cyclohexyl-
3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate 
(CMC), and morpholine were obtained from Aldrich (Milwaukee, 
WI). The LiChrospher SI 500 (10 pm diameter, 500 X pore size) 
and Nucleosil (10 pm diameter, 50 X pore size) were from 
Alltech (Deerfield, IL). The N-Hydroxysuccinimide was from 
Eastman (Rochester, NY), the n-ootyldimethylchlorosilane from 
Petrarch (Bristol, PA), and the carboxylate microspheres (0.1 
pm diameter) from Folysciences (Warrington, PA). 
Instrumentation 
The chromatographic system consisted of a Series 344 
gradient elution chromatograph (Beckman, Berkeley, CA) and a 
detector (ISCO, Lincoln, NE) operated at 280 nm. Data were 
collected and processed with an Apple lie computer and ADALAB 
interface (Interactive Microware, State College, PA). The 
columns were of a published design (79), with the outer 
connector modified as a water jacket. A Model 705 stirred-
slurry column packer (Micrometrics, Norcross, GA) and Haskel 
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air-driven pump from Alltech were used in column packing by 
the upward-slurry pack method. 
Procedures 
Preparation of protein ^  supports 
The diol-bonded LiChrospher and Nucleosil were prepared 
as described previously (80). Three methods were used to 
immobilize protein A on these supports. In each case 1 to 2 
mL of 0.1 M potassium phosphate buffer was added to 0.1 g of 
activated silica. This mixture was degassed under sonication 
and aspirator vacuum for 15 min. A total of 10 mg of protein 
A/g silica was then added and the mixture shaken at 4 °C for 3 
to 6 days. 
The first immobilization technique used was the Schiff 
base (SB) method, as summarized in Figure 2. In this method, 
diol-bonded silica, shown at the top of Figure 2, is oxidized 
with periodic acid to produce aldehyde groups on the surface 
of the support. When protein is added to a suspension of this 
silica, free amine groups on the protein react with these 
aldehyde groups to form a Schiff base. In the presence of a 
mild reducing agent, such as sodium cyanoborohydride, the 
Schiff base is reduced upon formation to give a stable 
secondary amine linkage between the protein and the support 
(25). 
gure 2. The Schiff base immobilization method 
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OH OH 
I I 
Support-CH-CH2 
+ HIO^ 
Support-C(^ 0 
H 
+ RNH2 + NoBH^CN 
Support-CH2-NH-R 
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The Schiff base method used in this experiment was a 
modified version of the procedure developed by Larsson and co­
workers (25). The support was activated with aldehyde groups 
by adding 0.1 g diol-bonded silica to 5 mL of a solution 
containing 5 mg/mL periodic acid in 80% acetic acid. This 
mixture was degassed as described previously and shaken at 
room temperature for 30 min. The silica was then collected by 
filtration, washed with methanol, and dried under aspirator 
vacuum. Next, the silica was placed in pH 5.7 phosphate 
buffer along with 200 mg sodium cyanoborohydride/g silica and 
degassed. After degassing, the protein A was added and 
allowed to react with the silica for 6 days. 
The second immobilization technique used was the GDI 
method, shown in Figure 3. Diol-bonded silica is also the 
starting material for this method but in this case is acti­
vated by reacting it with GDI to place imidazolyl carbonate 
groups on its surface. When protein is added to a solution 
containing this activated silica, free amines on the protein 
displace these groups to form alkyl carbamate bonds between 
the protein and the support (81). 
The GDI supports in this experiment were synthesized 
according to a previously-published procedure (81). The 
activated matrices were prepared as^described in the 
gure 3. The GDI immobilization method 
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Support-OH 
+ carbonyldiImidazole 
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+ RNHg 
Ni/ ;i 
Support-0-C-NH-R 
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reference, placed along with protein A in phosphate buffer at 
pH's ranging from 4.0 to 8.0, and allowed to react for 6 days. 
The last method used was the ester-amide (EA) method, 
given in Figure 4. In this technique, diol-bonded silica is 
activated through a series of reactions which place N-
hydroxysuccinimide groups on its surface. In the presence of 
free amines, these groups are displaced forming an amide bond 
between protein and the support material. 
The EA procedure used was based on that developed by 
Landgrebe et al. (44). In this method, a mixture of 0.1 g of 
diol-bonded silica, 0.25 g of succinic anhydride, and 5 mL of 
0.001 M hydrochloric acid in dioxane was prepared and refluxed 
for 48 h. The silica was then filtered, washed with warm 
dioxane, and dried under aspirator vacuum. This was activated 
by combining it with 20 mg of N_-hydroxysuccinimide, 75 mg of 
CMC, and 1.0 mL of dioxane followed by degassing and shaking 
for 2 h at room temperature. The product was filtered, washed 
with dioxane and methanol, and dried under aspirator vacuum. 
The silica was then placed in pH 6.0 phosphate buffer along 
with protein A and allowed to react for 3 days. 
After coupling, the protein A silicas prepared by each 
immobilization method were centrifuged, washed with 2 M sodium 
chloride and water, and stored at 4 °C in 0.1 M pH 7.0 
phosphate buffer. A portion of each sample was washed with 
Figure 4. The ester-amide immobilization method 
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water and vacuum-dried at room temperature. These were later 
assayed for protein content in triplicate by the Lowry method 
(82) using protein A as the standard and diol-bonded silica as 
the blank. The remainder of each protein A silica was vacuum 
slurry-packed (83) into 6.35 mm x 4.1 ram I.D. and 6.35 mm x 
2.1 mm I.D. columns. 
Under the reaction conditions given, all three of the 
immobilization methods were found to introduce approximately a 
monolayer of active groups onto the support. The diol 
coverages of the supports prior to activation were determined 
using the periodate oxidation method (84,85). This gave diol 
coverages of 760 praol/g silica for the Nucleosil, 200 (nmol/g 
for the LiChrospher used in the SB and EÂ methods, and 250 
pmol/g for the LiChrospher used in the GDI method. 
Preparation of reversed-phase supports 
The LiChrospher and Nucleosil reversed-phased supports 
were prepared according to published procedures (83,86) by 
placing 0.2 g of silica in 1.0 g of n-octyldimethylchloro-
silane and 10 g of carbon tetrachloride. The LiChrospher and 
Nucleosil supports were then vacuum slurry-packed into 6.35 mm 
X 1 mm I.D. and 2.55 mm x 1 mm I.D. columns, respectively. 
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Chromatography 
The application buffer for the protein A columns was 0.1 
M potassium phosphate buffer (pH 7.0). All IgG solutions 
applied to the protein A affinity columns were prepared in 
this buffer. The elution buffer for these columns was 0.1 M 
potassium phosphate buffer (pH 3.0). Elution of adsorbed IgG 
was accomplished by means of a step change in pH. 
The weak mobile phase for the reversed-phase columns was 
0.02 M ammonium acetate (pH 7.0) containing 0.01% (v/v) 
morpholine. All IgG solutions used in the reversed-phase work 
were prepared in this buffer. Elution of retained protein 
from the reversed-phase columns was accomplished by using a 
linear 5 min gradient from 0 to 100% 2-propanol. 
Kinetic studies on both the protein A and reversed-phase 
supports were performed at 25 oC. All other chromatography 
was done at room temperature. 
The static adsorption capacity of each protein A support 
was found by continuously applying 0.1 mg/mL IgG to the 6.35 
mm X 2.1 mm I.D. column prepared for each sample. The 
capacity was determined by integrating the resulting break­
through curves (87) and correcting for the void volume of the 
system. All protein A columns were pretreated several times 
in this manner to eliminate any residual active groups or 
irreversible adsorption sites. 
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The split-peak behavior of the protein A supports was 
examined using the 6.35 mm x 4.1 mm Z.D. columns. For each 
column, 10 pL injections of IgG were made at 3 to 5 concen­
trations ranging from 0.14 to 2.2 mg/mL. These studies were 
done over flowrates of 0.25 to 4.0 mL/min for the SB- and EA-
immobilized protein A columns and 0.02 to 0.40 mL/min for the 
CDI-immobilized protein A support. The areas of both the 
retained and nonretained peaks were determined by computer 
integration and, in some cases, checked with a planimeter. 
These areas were then normalized vs. flowrate. The non-
retained peak areas were corrected for an inactive impurity in 
the IgG, which made up a maximum of 2.0% of the total IgG 
area. The retained peak areas were corrected for a pre-
viously-noted impurity in the phosphate buffer (88), which 
concentrated on the column at pH 7 but eluted when the pH was 
decreased to 3. The area resulting from this impurity was 
easily calculated since it was a linear function of the volume 
of pH 7 buffer applied. This peak is believed to be caused by 
the retention of transition metal ions on the support since 
its size could be reduced by first passing the buffer through 
a chelating resin. 
A check on these integration and correction procedures 
was made by normalizing the total area of both peaks vs. the 
flowrate and the amount of IgG applied. By doing this, it was 
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determined that the total normalized area varied randomly by 
less than 6% (1 standard deviation) during the course of the 
experiments, confirming the validity of the procedures used. 
The nonretained fraction f of IgG eluting from the 
protein A columns was calculated by dividing the corrected 
nonretained peak area by the total corrected area of the 
nonretained and retained peaks. This was possible since it 
was found that the IgG peak area increased linearly with 
sample size over the entire concentration range studied. 
The value of k^ was measured isocratically by injecting 
IgG on diol-bonded silica columns, to which IgG does not 
adsorb. The columns used were 10 cm x 4.1 mm I.D. and were 
packed at 3000 p.s.i. using the upward slurry-pack method. 
Using pH 7.0 phosphate buffer as the mobile phase, 10 pL 
injections of 2.2 mg/mL IgG were made on the column at 
flowrates of 0.25 to 3.0 mL/min. The statistical moments of 
each peak were determined using the Gaussion approximation 
method (69). Corrections for the extracolumn volume were made 
by injecting 10 pL of 16 pg/mL uracil, a small nonretained 
solute, on the system with the column removed. The void and 
excluded volumes of the columns were measured by injecting 10 
pL of 2.2 mg/mL IgG and 0.25% carboxylate microspheres, 
respectively. In the case of the microspheres, the mobile 
phase was deionized water, which was also used to prepare 
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the sample solution. This was used to prevent agglomeration 
of the microspheres. 
The split-peak estimate of kj^ was obtained by injecting 
IgG on reversed-phase columns. For the reversed-phase 
LiChrospher supports, a 3 |iL sample of 0.90 to 1.50 mg/mL IgG 
was injected while a 3 ]iL sample of 0.25 to 0.50 mg/mL IgG 
was used for the Nucleosil. These studies were done over 
flowrates ranging from 0.20 to 2.0 mL/min. The nonretained 
peak area was found as described earlier and the fraction f 
was calculated by dividing this area by the total area of the 
sample, corrected for the inactive impurity, when injected 
through an open tube. This was possible since it was found 
that the peak area for IgG in the ammonium acetate buffer 
increased linearly with sample size over the entire concen­
tration range studied. 
54 
RESULTS AND DISCUSSION 
Static Properties of Immobilized Protein A 
In the first part of the experiment, the static 
properties of the various protein A supports were determined. 
In describing these supports, each will be referred to in 
terms of the immobilization method and support material used 
to prepare it. For example, protein A immobilized on 
LiChrospher SI 500 by the Schiff base method will be referred 
to as the SB-500 support. 
The static properties of the protein A supports are given 
in Table I. The intervals used in this and in all following 
tables represent a range of one standard deviation. The 
rather large standard deviations reported are due to the small 
sample sizes (0.6 to 3 mg silica) used in the protein assay 
and variability caused by the silica support. Despite this, 
it is clear from the data that all three methods resulted in 
the immobilization of 86 to 100% of the protein A. For the 
LiChrospher, each method gave a coverage of approximately 10 
mg of protein A/g silica. This represents about one-third of 
a monolayer, based on a Stoke's diameter for protein A of 100 
A (46). 
The Nucleosil SI 50 also gave a high coupling yield, with 
a coverage of approximately 9 mg/g silica. This nearly quan-
Table I. Static properties of protein A supports 
Immobilization 
method Support Batch 
Protein A 
immobilized 
(mg/g silica) 
GDI LiChrospher 1 (pH 8) 9.0 + 2.6 
SI 500 2 (pH 6) 8.6 + 1.8 
3 (pH 4) 10.2 + 1.8 
Average 9.3 ± 1.9 
EA LiChrospher 1 11.3 + 2.3 
SI 500 2 8.2 + 0.4 
Average 9.7 + 2.2 
SB LiChrospher 1 9.6 ± 0.9 
SI 500 2 
o 
10. 7 ± 1.8 
Average 10.1 + 1.4 
Nucleosil 1 9.0 ± 0.4 
SI 50 
®Based on the manufacturer's value for the initial 
activity of the protein A. The initial activity of the 
protein A used in preparing the SB Nucleosil and GDI supports 
was given as being 12.5 mg IgG/mg protein A and that used for 
the EA and SB LiChrospher supports was given as being 13.1 mg 
IgG/mg protein A. 
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% Protein A Static capacity Specific % Initial 
immobilized (mg IgG/g silica) activity (mg protein A 
IgG/mg protein A) activity^ 
90 + 26 4.7 + 1.4 0.5 + 0.2 4.2 
87 + 18 5.1 ± 0.7 0.6 ± 0.1 4.8 
102 ± 18 7.0 ± 2.5 0.7 ± 0.2 5.5 
93 + 19 5.7 + 1.9 0.6 + 0.2 4.8 
97 + 20 8.0 ± 1.0 0.7 + 0.2 5.4 
76 ± 4 9.7 ± 1.3 1.2 ± 0.2 9.0 
86 ± 8 8.8 ± 1.3 0.9 ± 0.2 7.2 
87 + 8 21.5 ± 2.7 2.2 ± 0.3 17.1 
89 ± 15 23.5 ± 1.7 2.2 + 0.4 16.8 
15.7 ± 0.5 — — — • • — — — — — — — 
88 + 11 19.8 ± 4.2 
Cs
l 
+ 
CO o
 17.0 
90 ± 4 5.1 ± 
1—
1 o
 0.57 ± 0.03 4.5 
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titative binding of protein A to Nucleosil was unexpected 
since the Stoke's diameter of protein A is twice the nominal 
pore size of Nucleosil SI 50. This can be explained by the 
fact that roughly 25% of the pores in most commercial silicas 
have diameters greater than twice the nominal pore size (89). 
Combined with the ten-fold greater surface area of Nucleosil 
SI 50 vs. LiChrospher SI 500, this may have resulted in more 
area actually being available for protein attachment on the 
Nucleosil SI 50 than on the LiChrospher SI 500. Another 
contributing factor may have been the elongated shape of 
protein A (46,48), which could have permitted it to enter some 
of the pores of the Nucleosil along its long axis, again 
creating more surface area for protein A attachment. 
Table I also gives the activity obtained for each protein 
A support. Of particular interest are the last two columns, 
which list the specific activity of the protein A and the 
percent of its initial activity remaining after immobiliza­
tion. The latter is based on values given by the manufacturer 
for the binding of human IgG to protein A, which should 
represent a protein A binding capacity equivalent to that 
obtained with rabbit IgG (50). The data in Table I indicate 
that 83 to 96% of this initial activity was lost due to 
immobilization. 
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Losses of activity are common when macromolecules are 
immobilized (29,90). For protein A this probably occurs 
because native protein A is specifically attached to the 
bacterial cell wall through its cell wall binding region 
(48), while the relatively nonspecific immobilization methods 
used here can couple it via any accessible amine groups. This 
may have resulted in multiple points of attachment between 
protein A and the support, causing possible denaturation or 
improper orientation of protein A on the support, resulting in 
inactivation or steric hinderance of its binding site (11). 
A comparison of the LiChrospher results in Table I shows 
that the SB method gave immobilized protein A with about twice 
the specific activity of that produced by the EA method and 
four times that given by the GDI method. Since each method 
introduced approximately the same number of active groups 
onto the support, this may reflect differences in the 
reactivity of these groups in binding free amines on the 
protein or may indicate differences in the microenvironment 
of the resulting immobilized ligand (29,90). Such differ­
ences are further indicated by the fact that the activities 
varied even when each technique was allowed to sample the same 
free amine groups on the protein A. This can be seen by 
comparing the SB-500, EA-500, and CDI-500-2 results, all 
59 
prepared using approximately the same pH and ionic strength 
conditions in the immobilization step. 
Differences can also be observed in the activities of the 
SB-50 and SB-500 protein A, with the Nucleosil support having 
an activity only one-fourth of the corresponding LiChrospher 
phase. Since both supports were prepared by the same method, 
this may indicate differences in the relative amount of 
protein A on each support that was able to bind to IgG. For 
example, most of the protein A in the pores of the Nucleosil 
was probably unavailable for binding to IgG, due to the narrow 
pore size of the support or steric hindrance created by 
ligands present near the entrance of the pores. Either of 
these effects could have prevented IgG from reaching ligand 
sites further within the support. 
Kinetic Properties of Immobilized Protein A 
After the static properties of each support had been 
examined, their kinetic properties were also determined. This 
was accomplished by measuring the amount of nonretained IgG on 
each support as a function of flowrate. Some typical chromat-
ograms obtained are given in Figure 5. In this figure, the 
two peaks characteristic of the split-peak effect can be seen, 
representing the nonretained and retained IgG fractions, 
respectively. Figure 5 also demonstrates how the relative 
Figure 5. The split-peak effect for IgG on immobilized 
protein A. The chromatograms shown are for 10 pL 
of 2.2 mg/mL rabbit IgG applied to the EA-500 
column at flowrates of 1.50 (a), 1.75 (b), 2.00 
(c), and 2.25 (d) mL/min. The IgG was applied at 
the first arrow. The bound IgG was eluted by a pH 
step change applied at the second arrow. The small 
peak immediately following the second arrow repre­
sents a background shift due to the pH step change 
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amount of bound and free IgG changes with flowrate, with the 
nonretained peak area increasing and the retained peak area 
decreasing as the flowrate is increased. By varying the 
flowrate in this experiment, it was possible to change the 
amount of nonretained IgG from a few percent at low flowrates 
to almost 50% when higher flow rates were used. During the 
course of these studies, the protein A columns were noted to 
be quite stable, as found previously (27), with both their 
kinetic and static behavior being reproducible throughout the 
course of the experiment. 
Once the amounts of nonretained and retained IgG had been 
determined at various flowrates, the data were then plotted 
according to Equation 26. Examples of these plots are given 
in Figure 6. Each line shown is the linear least-squares fit 
through the origin for the corresponding data set. Except for 
the SB-500 22 Jig results, all data in Figure 6 are for the 
next-to-smallest sample studied on each column, so that the 
scatter of these plots is representative of the entire data 
set. Note that for each plot the linear relationship pre­
dicted by Equation 26 was observed. This indicated that, for 
the purpose of quantitation, the model used here did give an 
adequate description of the split-peak effect. 
In comparing these plots, it can be seen that different 
slopes were obtained with the various protein A supports under 
Figure 6. Typical split-peak plots for IgG on protein A 
columns. The columns and samples sizes represented 
are as follows: SB-500, 22 pg IgG (O)» SB-500, 11 
pg IgG (#); SB-50, 15 pg IgG (A); CDI-500, 2.7 pg 
(•); and EA-500, 8.2 pg C^) 
64 
0.88 
0.66 
0.22 
0 0 1 
Flowrate (mL/min) 
65 
similar operating conditions. Based on Equation 2 6 ,  this can 
be used as an indication that the supports differed in their 
kinetic properties, with the slopes increasing as the rate of 
analyte adsorption decreased. It was determined qualitatively 
from these slopes that the CDI-500 support had the slowest 
adsorption kinetics, while the SB-50 support exhibited the 
fastest adsorption kinetics. 
These differences were examined more quantitatively by 
evaluating the individual parameters in the slope obtained 
for each support. This required that slopes independent of 
sample size be used in order to fulfill the assumptions made 
in deriving Equation 26. To see if these values were inde­
pendent of sample size, the split-peak slope of each support 
was measured at several different sample loads using the same 
type of least-squares fit as performed in Figure 6, These 
slopes were then plotted vs. sample size, as shown in Figure 
7. It was found for each affinity support and sample load 
studied that the data gave the linear response predicted by 
Equation 26. However, it was also found that the slopes 
obtained with these supports increased with sample size. 
Since each data set gave an apparently linear relationship 
between the slope and sample load, a linear least-squares fit 
was used to extrapolate to the slope at zero sample size. The 
Figure 7. The change in the split-peak slope with sample size 
for IgG on protein A columns. The columns repre­
sented are the CDI-500 (H)> EA-500 (^), SB-500 
(#), and SB-50 (A)« The split-peak slopes for 
the CDI-500 column were ten-fold larger than shown 
Slope (min/mL) 
o 
CO 
o 
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extraploted slopes obtained from this procedure are given in 
Table II. 
These extrapolated slopes were used to calculate the 
value of kg for each of the affinity supports. This required 
that independent values of Vg, and also be known. Vg 
and niL were determined as discussed previously, with the 
results given in Table II, Estimates of k^ were obtained by 
using the two methods described earlier. In the first of 
these methods, the band-broadening of IgG under isocratic 
elution conditions was studied using 10 cm diol-bonded 
LiChrospher SI 500 and Nucleosil SI 50 columns. Plots of H 
vs. u were then made, as shown in Figure 8. In both cases, 
the linear relationship predicted by Equation 32 was observed. 
From the slope of these plots, ki was calculated to be 4.0 s~^ 
and 36 s~^ for the LiChrospher SI 500 and the Nucleosil SI 50, 
respectively. The larger k^ value for the Nucleosil support 
indicates that it was a more efficient support (i.e., had 
faster mass transfer kinetics) than the LiChrospher. This was 
expected since it was found that IgG could enter approximately 
96% of the LiChrospher pore volume, while on the Nucleosil it 
could only penetrate about 15% of the pores. This caused the 
Nucleosil to behave like a nonporous or pellicular support for 
the IgG, giving it faster mass transfer kinetics than the 
LiChrospher support. 
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Table II. Column parameters for kinetic studies 
Column Extrapolated 
slope (s/mL) 
Ve* 
(pL) 
mL^ 
(nmol) 
CDI-500-3° 52 ± 14 27 1.4 
EA-500-1 11.1 ± 2.4 27 1.6 
SB-500-3 12.8 ± 0.5 27 3.2 
SB-50-1 8.7 ± 0.3 22 1.0 
^Estimated from the isocratio studies. 
^Calculated from the IgG static capacity in Table I using 
an experimentally-determined packing density of 0.38 g/mL for 
the LiChrospher SI 500 and of 0.37 g/mL for the Nucleosil SI 
50. 
°Batch number from Table I. 
Figure 8. Total plate height vs. linear velocity for IgG on 
diol-bonded silica columns. The supports used were 
diol-bonded LiChrospher SI 500 (#) and Nucleosil 
SI 50 (•) 
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The second estimate of was obtained by performing 
split-peak experiments with IgG on short reversed-phase 
columns, with the assumption that diffusion was the rate-
limiting step in protein adsorption. Figure 9 shows the 
results obtained when the data were plotted according to 
Equation 27. Like the affinity results in Figure 6, these 
results also showed the linear relationship predicted by the 
model. These plots did differ from those in Figure 6, 
however, in that no sample size dependence of the slope was 
noted over a two-fold range in IgG concentration. The reason 
for this difference between the two systems will be discussed 
in Section III. By performing the same type of linear fit to 
the data as used in Figure 6, values for ki of 8.6 s~^ and 149 
swere obtained for the LiChrospher and Nucleosil supports, 
respectively. The larger ki value for the Nucleosil SI 50 
again indicates that it was a diffusionally more efficient , 
support for IgG than the LiChrospher SI 500. 
A comparison of the isocratic and split-peak values of k^ 
reveals that the ki estimates of both supports were larger 
when the split-peak method was used. One way in which this 
can be explained is based on heterogeneity of the chromato­
graphic system. All columns are somewhat heterogeneous due to 
variability in the particle size of the support, nonuniformity 
in the packing structure of the column, differences in the 
Figure 9. Split-peak plots for IgG on reversed-phase columns. 
The two columns used contained LiChrospher SI 500 
( # ) and Nucleosil SI 50 (H) reversed-phase 
supports 
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binding strength of the adsorption sites, and other factors 
(31,66). The result is that a range of different kinetic 
processes are actually present, making the rate parameters 
used here apparent rate constants, or functions of these 
individual processes. This may have affected the results 
obtained if the two methods used to estimate k^ responded 
differently to heterogeneity. For example, in the isocratic 
studies, band-broadending was used as the basis of the 
measurement. Since band-broadening is predominantly caused by 
the slowest kinetic processes in the column, the values of kj 
obtained would be expected to be weighted toward the smaller 
rate constants. In the split-peak studies, kx is measured 
based on retention of analyte via a single adsorption step. 
Since the majority of analyte is probably retained by the 
fastest adsorption processes, the k^ values obtained here 
should be weighted toward the larger k^ values. Therefore, it 
is reasonable that the k^ values determined by the split-peak 
method were larger than those obtained by the isocratic 
method. 
Regardless of whether or not such effects were present, 
it was possible to use these estimates of k% to more closely 
examine the kinetic properties of the protein A supports. The 
results obtained when this was done are summarized in Tables 
III and IV. By using these estimates of k% to calculate 
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Table III. Kinetic data from isocratic studies 
Column (s-1) 1/ki Vg (s/mL)* kg (M-1 s-l)b 
CDI-5OO-3C 4.0 9.2 (1 .7 + 0.8) X 104 
EA-500-1 4.0 9.2 ~3 X 105 
SB-500-3 4.0 9.2 ^8 x'lO* 
SB-50-1 36. 1.3 (1 .3 + 0.4) X 105 
^Calculated using the Vg values from Table II. 
^Calculated using the extrapolated slopes from Table II. 
°Batch number from Table I. 
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Table IV. Kinetic data from split-peak studies 
Column k^ (s"^) 1/ki Vg (s/mL) ^ k3 (M-1 s-l)b 
CDI-500-3° 8.6 4.3 (1.5 + 0.7),x 10^ 
EA-500-1 8.6 4.3 "9 X 107 
SB-500-3 8.6 4.3 -4 X 10^ 
SB-50-1 149. 0.31 (1.16 ± 0.04) X 10^ 
^Calculated using the Vg values from Table II. 
^Calculated using the extrapolated slopes from Table II. 
°Batch number from Table I. 
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1/kl Vg and by comparing this to the extrapolated slope of 
each affinity column, it was found that two of the supports, 
the CDI-500 and SB-50, were primarily adsorption-limited, 
while the others had both diffusion and adsorption contrib­
uting significantly to the overall rate of retention. Thus, 
for the CDI-500 and SB-50 supports actual values of k3 could 
be calculated, while for the other supports only rough 
estimates could be made. The kg values obtained for each 
support are also given in Tables III and IV. 
In examining these values, it was found that the SB 
method, based on the SB-50 data, gave immobilized protein A 
with a k3 value of approximately 1.2 x 10^ s~^. Similar 
results, although less precise, were obtained for the SB-500 
and EA-500 supports. The GDI method, however, gave 
immobilized protein A with a kg value of only 1.6 x 10^ M~^ 
s-1. This clearly indicates that the immobilization method 
used in preparing protein A supports can significantly affect 
the kinetic properties of the protein A. 
Note that by combining these results with the site 
heterogeneity argument presented earlier, it is possible to 
explain the sample size dependence of the split-peak slope 
observed in Figure 7. For example, if there are a range of 
adsorption rates present in a system, it would be expected 
that solute would tend to fill those sites with the fastest 
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rate of adsorption first. Thus, as sample size is increased, 
the kinetics should appear to become slower and the measured 
split-peak slope should increase. This is exactly what was 
observed in Figure 7. To carry this even further, one would 
expect that very heterogeneous columns would tend to be the 
most sensitive to such effects. For instance, if it is 
assumed that the ligand in the SB and EA columns was pri­
marily homogeneous or native protein A, then the kinetically 
slower GDI column probably contained protein A in a more 
heterogeneous state, with a possible range of kg values all 
the way from that of native protein A to less than the value 
actually measured. The predicted result would be a larger 
change in slope with sample size for this support, as was seen 
in Figure 7. 
Since no known literature values for the adsorption rate 
constant of protein A have been published, it is not possible 
to determine whether or not the kg value for the SB-50 data of 
1.2 X 10^ s~^ is the true adsorption rate constant for 
protein A. However, the binding of antibody with antigens, a 
similar set of reactions with which protein A competes for 
immunoglobulins, has typical adsorption rate constants in the 
range of 10^ to 10® s"^ (91), so this result is certainly 
reasonable. 
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The equilibrium binding constant for Sephadex-immobilized 
protein A and rabbit IgG has been previously reported to be 
4.1 X 10® (92). Assuming that this is also true for the 
system studied here and that the SB-50 value of kg is the true 
adsorption rate constant, then a value for k-3 of 2.9 x 10"^ 
s~^ is obtained. This value compares favorably with typical 
antibody-antigen dissociation constants of 10"^ to 10~2 s~^ 
(91), also indicating that the results obtained in this 
experiment are reasonable. 
81 
CONCLUSIONS 
In this experiment, it was found that IgG adsorption on 
both affinity and reversed-phase columns gave the linear 
response between -1/ln f and flowrate predicted by the model. 
It was concluded from this that the model gave an adequate 
description of the split-peak effect, especially in terms of 
quantitating this phenomenon. This makes it useful for a 
number of applications, such as the evaluation and optimi­
zation of the performance of chromatographic supports. 
Supports can be evaluated or compared by simply measuring the 
split-peak slope for each under similar operating conditions. 
The support with the fastest rate of adsorption can then be 
determined by choosing that giving the smallest split-peak 
slope. This was illustrated with the protein A data in Figure 
6, where it was found that the SB-50 gave the smallest slope 
and fastest kinetic properties of any of the protein A 
supports studied. 
If estimates of and Vg are also known, even more 
information about the kinetics of the supports can be 
obtained. For example, kj^ and Vg can be used to determine 
the size of the diffusional term of the split-peak slope. 
This allows one to determine whether adsorption or diffusion 
is the rate-limiting step in analyte retention. By doing this 
with the protein A data, it was found that two of the supports 
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were adsorption-limited, while the others had both adsorption 
and diffusion contributing to the overall rate of retention. 
This type of information is useful in improving the perform­
ance of chromatographic supports. For example, if diffusion 
is found to be rate-limiting, it may be possible to increase 
the rate of analyte retention by using a support with a 
smaller particle diameter, increasing both k.% and k_i 
according to Equation 31. If adsorption is rate-limiting, it 
may be possible to use a higher li'gand coverage (i.e., an 
increased value of m^) to increase the rate of retention. 
In this experiment, this approach was carried even 
further by using values of m%,, ki, and Vg to determine the 
value of k3 for each protein A support. From the results 
given in Tables III and IV, it was found that kg varied by up 
to ten-fold depending on which immobilization method was used 
in preparing the supports. This is significant since it 
indicates that the kinetic properties of an affinity ligand 
can be affected by the immobilization method used to prepare 
it. Thus, it is important to consider this in choosing a 
coupling method. The results presented suggest that the 
Schiff base technique is the immobilization method of choice 
for protein A, since it gave ligand with both superior static 
and kinetic properties vs. that obtained with either the EA 
or GDI methods. 
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This last set of studies also suggests that the split-
peak method might be useful in the measurement of adsorption 
rate constants for macromolecular interactions. If this is 
the case, then this technique would offer several potential 
advantages over the present isocratic method. For example, 
since it is based on an area rather than a peak width 
measurement, it is not as susceptible to extracolumn band-
broadening as the isocratic method. It should also be more 
precise, since peak areas can be much more precisely measured 
than peak widths or variances (69). A third potential advan­
tage of this method is that techniques other than peak area 
measurements can be used to obtain the retained and non-
retained fractions. This can be done by simply collecting 
these fractions as they elute from the column and later 
analyzing them with the desired technique. 
Another advantage of this method is that it does not 
require the use of biospecific elution, a technique often 
needed with the isocratic method. Recall that in biospecific 
elution a species that competes for analyte or ligand binding 
sites is added to the mobile phase to elute analyte from the 
column. Although this is an easy way of isocratically eluting 
analyte, it can cause problems in analyte detection. As a 
result, the use of the isocratic method has been largely 
limited to systems which have compelling species that are 
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significantly different from the analyte, such as the binding 
of enzymes with inhibitors or substrates (29,90). A similar 
detection problem can occur in other kinetic methods used in 
studying biological systems, such as stopped-flow analysis or 
perturbation techniques (93). This is not a problem with the 
method presented here, since the free and bound analyte are 
readily separated and nonspecific as well as biospecific 
elution techniques can be employed. This makes this technique 
potentially useful for studying a wide variety of macromolec-
ular interactions, especially those involving similar inter­
acting species. In order for this method to be useful for 
this, however, further work must first be done to determine 
how the rate constants obtained with this approach compare to 
the results of other techniques. 
Further work is also needed to explain the sample size 
dependence of the split-peak slope. In some applications, 
such as the comparison of the overall adsorption kinetics of 
affinity supports, it may be possible to deal with this by 
careful standardization of the column size and sample load 
conditions. For the determination of rate constants, however, 
a better understanding of this effect is needed to allow the 
results to be minimized or corrected for it. Studies in this 
area will be presented in Section III. Also in Section III, 
the reason for the differences in the split-peak dependence of 
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affinity and reversed-phase columns will be examined. The 
effect of heterogeneity and other secondary effects on this 
dependence will also be further discussed. 
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SECTION II. 
DESIGN AND OPTIMIZATION OF A DUAL-COLUMN AFFINITY 
CHROMATOGRAPHIC SYSTEM 
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INTRODUCTION 
In the previous chapter, it was demonstrated how the 
split-peak effect can be used in comparing and evaluating the 
adsorption kinetics of chromatographic supports. This makes 
it useful in choosing or designing more efficient supports, 
allowing faster separations. However, the problem still 
remains as to how to deal with the split-peak effect when it 
appears on supports that have already been prepared or on 
columns already in use. For these cases, a technique is 
needed to determine what conditions must be used to give the 
desired degree of retention in the minimum amount of time. 
In this experiment, such a technique is presented which allows 
the evaluation of support adsorption kinetics through the use 
of a single rate parameter. The method is demonstrated by 
using it in the design and optimization of an HPAC analytical 
separation. 
The separation developed in this work is one of clinical 
interest, the determination of two serum proteins. HPAC 
was chosen as the basis for this separation since its high 
selectivity enables it to be used for the determination of one 
or a few species in complex samples, such as serum or urine, 
with little interference from other components. This makes 
HPAC potentially useful in clinical chemistry, where such 
samples are commonly encountered. An example of the current 
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use of low-performance affinity chromatography in this field 
is the determination of glycosylated hemoglobins in blood 
(94). In this experiment, a method is developed for the 
determination of human serum albumin (HSA) and IgG in serum. 
HSA is the most commonly determined of the serum proteins 
(95). It is the major protein component of serum, making up 
50 to 65% of the total protein content, with typical concen­
trations of 35 to 52 g/L (96). Presentlyrused methods for 
determining albumin include spectrophotometry, electro­
phoresis, and single radial immunodiffusion (SRID) (95,96). 
Albumin is of interest clinically because its serum concen­
tration is a general indicator of disease and the nutritional 
state of an individual. For example, decreases in HSA levels 
can occur due to protein loss (such as occurs in kidney 
damage, severe hemorrhages, and burns), decreases in protein 
synthesis or intake (as takes place in malnutrition, 
starvation, and liver cell damage), or overhydration (95-99). 
The determination of immunoglobulin levels in serum is 
also of clinical interest. In humans, the immunoglobulins (or 
circulating antibodies) consist of five known classes: IgG, 
IgA, IgM, IgD, and IgE. Of these, IgG is the most abundant in 
serum, making up 75 to 80% of the immunoglobulin fraction. 
Normal levels of IgG vary from 7.0 to 16.8 g/L (96). IgA and 
IgM also occur at significant levels in serum with concen­
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trations of 1.4 to 2.2 and 0.80 to 1.20 g/L, respectively, but 
IgD and IgE occur in only trace amounts (i.e., less than 0.2% 
of the total immunoglobulin fraction) (98). Immunoglobulin 
levels are commonly determined by electrophoresis, immuno-
electrophoresis, SRID, nephelometry, and radioimmunoassay 
(RIA) (96,98,99). These levels are of interest since they are 
altered by many diseases and indicate the state of the humoral 
immune system (96,98). For example, increases in the serum 
IgG levels can be an indication of infection or liver disease. 
Abnormal levels of IgG can also be the result of disorders of 
the immune system such as occur in autoimmune or monoclonal 
diseases and acquired immunodeficiency syndromes (99). 
Possible affinity ligands for these proteins include 
immobilized anti-HSA antibodies for HSA (24) and protein A for 
IgG (26,27). As discussed in the preceding chapter, the 
ability of protein A to bind to immunoglobulins has made it a 
useful ligand for isolating several types of IgG, including 
human IgG (26,27). Of the four subclasses of human IgG (i.e., 
IgG^ through IgG^), protein A binds all but IgGg, which is not 
adsorbed or only slightly bound to protein A (50,100), IgGg 
represents 5 to 9% of the total IgG fraction (101). 
In this work, these affinity ligands were used in a dual-
column system to allow both HSA and IgG to be determined from 
a single serum sample. Such an approach has the advantage of 
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retaining the high selectivity of each affinity, matrix while 
allowing vastly different components to be determined 
simultaneously. A general scheme is presented here for the 
design and optimization of such multi-analyte affinity 
systems based on the kinetic properties of the supports as 
well as their static properties and elution characteristics. 
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THEORY 
The kinetic properties of the supports were determined 
using the split-peak method described in Section I. In the 
preceding section, the relationship between the flowrate and 
fraction of analyte eluting in the nonretained peak was given 
as 
-1 1 1 
= F ( + ) (26) 
In f ki Vg kg ML 
where a plot of -1/ln f vs. F yields a straight line with an 
intercept of zero and a slope equal to (1/k^ Vg + l/kg m^). 
It was pointed out earlier that each of the slope terms, 
1/ki Vg and l/kg m^, are inversely proportional to the column 
volume, Vcol» This is a result of the fact that Vg and m^ are 
related to Vcol by the equations 
V e =  E g  Vcol ( 3 3 )  
mi, = [L] Gp VqoI (34) 
where  Be  and  Cp  are  the  in terpar t i c l e  and  in t rapar t i c l e  
poros i t i e s  ( i . e . ,  Vg /Vco l  and  Vp/Vco l )  and  [L]  i s  the  l i gand  
concentra t ion  in  the  pore  vo lume ,  a s  de f ined  prev ious ly .  
Substituting Equations 33 and 34 into 26, an alternate 
form of the split-peak equation is obtained. 
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-1 F 1 1 
= ( + ) (35) 
in f Vcoi kl Sg kg [L] Gp 
Since all terras in the slope are now independent of column 
volume, these may be replaced by a single constant, C. 
Substituting this constant into Equation 35 yields 
-1 F C 
= (36) 
In f ^col 
By using Equation 36, then, the adsorption kinetics of a 
support can be described by a single parameter independent of 
both flowrate and column volume. Experimentally, C may be 
determined by injecting pure analyte into a column of known 
volume, measuring the fraction eluted in the nonretained peak 
at various flowrates, and deterraining the slope that results 
from a plot of -1/ln f vs. F/Vcol« 
-Note that Equation 36 is simply the integrated rate 
equation for a first-order reaction, where VQOI/F is the 
reaction time and C is the inverse of the apparent adsorption 
rate constant. The result is that C can be used to determine 
the time and column volume-flowrate combination needed to 
adsorb a given fraction of analyte. This makes it useful in 
optimizing sample application conditions. 
93 
EXPERIMENTAL 
Reagents 
The protein A, HSA, human IgG, human IgA, rabbit IgG, and 
affinity-purified goat anti-human IgG, anti-human IgA, and 
anti-human IgM antibodies were from Sigma (St. Louis, MO). 
The human IgM and the rabbit anti-HSA antisera were from Dako 
(Santa Barbara, CA). All biochemicals used were of the purest 
grades available. Reagents for the bicinchoninic acid (BOA) 
protein assay were from Pierce (Rockford, IL). The Coomassie 
Brilliant Blue G-250 was from Kodak (Rochester, NY), the 
agarose was from MCB (Norwood, OH) and the poly(ethylene 
glycol) (PEG), MW 8000, was from Aldrich (Milwaukee, WI). The 
LiChrospher SI 4000 and SI 500 (10 pm particle diameter, 4000 
X and 500 X pore sizes, respectively) were obtained from 
Rainin (Woburn, MA). The Serachem Clinical Chemistry Control 
sera were from Fisher (St. Louis, MO). 
Instrumentation 
The chromatographic and data acquisition systems used 
were the same as described in Section I, with the addition of 
a Rainin 7000 switching valve. This valve, placed after the 
anti-HSA column, contained the protein A column in place of a 
sample loop. This allowed the protein A column to be switched 
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off-line during part of the analysis. The detector was a 
Hitachi 100-10 (Tokyo, Japan) operated at 280 nra. The pH of 
each collected fraction was measured using an Orion 601-A 
pH/mV meter and a Bioprobe combination electrode from Fisher. 
A Bio-Rad 1420B power supply (Richmond, CA) was used for the 
electrophoresis and a Zeineh soft-laser scanning densitometer 
(LKB, Gaithersburg, MD) was used to analyze the gels. 
Procedures 
Preparation of protein A and anti-HSA supports 
Diol-bonded LiChrospher SI 4000 and SI 500 were prepared 
as described previously (80). The diol contents of the SI 
4000 and SI 500 prior to activation were 24 and 200 pmol/g 
silica, respectively, as determined by the periodate oxidation 
method (84,85). 
The protein A and anti-HSA matrices were prepared using 
the Schiff base method (25) with the modifications described 
in Section I. This method was chosen due to the superior 
kinetic and static properties obtained with it for protein A 
in the previous study. The protein A was coupled to the SI 
500 by using 10 mg protein A/g LiChrospher SI 500 in the 
immobilization step, and the anti-HSA was coupled by using 
2.0 mL of anti-HSA antiserum/g LiChrospher SI 4000. The 
protein A had a specific activity of 12 mg human IgG/mg 
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protein A, as determined by SRID (102). The HSA antiserum had 
a specific activity of 38.3 |ig HSA/mg protein, as determined 
by immunoprecipitation (103), and a protein content of 19.6 
g/L. The activated silica was placed in 2 raL of pH 5.7 0.10 M 
phosphate buffer/g silica and was sonicated under vacuum for 
15 min. The protein was then added and the mixture shaken at 
4 °C for 6 days. After 6 days, 500 mg of sodium borohydride/g 
silica was added to reduce any remaining activated groups 
(25). The samples were then centrifuged, washed with 2 M 
sodium chloride and water, and stored at 4 °C in 0.1 M pH 7.0 
phosphate buffer. Part of each sample was washed with water, 
vacuum-dried at room temperature, and assayed for protein 
content, using the BCA method (104) with protein A or IgG as 
the standard, and diol-bonded silica as the blank. The 
remaining protein A and anti-HSA silicas were then vacuum 
slurry-packed (83) into minicolumns of a published design 
(79). 
Chromatography 
The application buffer for both supports was 0.05 M 
phosphate 0.05 M citrate buffer (pH 7.0). The elution buffer 
was 0.05 M phosphate 0.05 M citrate (pH 3.0). The kinetic 
properties of both matrices were measured at 25 °C. All other 
chromatography was performed at room temperature. 
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The static adsorption capacity of each matrix was found 
by continuously applying 0.1 mg/mL human IgG or 0.01 mg/mL HSA 
to the appropriate matrices, packed in 6.4 mm x 4.1 mm I.D. 
columns. Both these and all other standard human IgG and HSA 
solutions were prepared in the pH 7.0 buffer. The break­
through capacities were determined by integration of the 
curves (87) and were corrected for the void volume of the 
system. 
The kinetic adsorption properties of both matrices were 
studied by the split-peak method described in Section I. The 
protein A kinetic studies were performed using rabbit IgG as 
the analyte under the same conditions as used earlier. For 
the anti-HSA matrix, a 12.8 mm x 4.6 mm I.D. column and a 50 
pL loop were used over a flowrate range of 0.5 to 0.75 mL/min. 
The elution of human IgG and HSA as a function of pH was 
studied using a 6.4 mm x 4.1 mm I.D. protein A column and a 
12.8 mm x 4.6 mm I.D. anti-HSA column. The columns were first 
saturated with 0.25 mg/mL human IgG or 0.08 mg/mL HSA, respec­
tively, at 0.50 mL/min. A series of step changes from 0 to 
100% pH 3.0 buffer were then made in 5% or 10% increments 
(i.e., 0.2 or 0.4 pH units) at 15 minute intervals. The area 
of the peak eluted at each pH was determined by planimetry 
after subtraction of a background run. A fraction was 
collected at each step change, and the pH was measured. 
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Quantitation of serum samples was performed at a 
flowrate of 1.0 mL/min using anti-HSA and protein A columns, 
connected in series, and a 10 pL sample loop. The standards 
were 2.0 to 14.2 mg/mL HSA and 0.5 to 4.0 mg/mL human IgG. 
The serum samples were diluted 1:5 with the pH 7.0 buffer 
prior to injection. After the nonretained peak had been 
eluted from both columns, the anti-HSA column was eluted with 
pH 3.0 buffer, keeping the protein A column switched off-line. 
After the HSA had been eluted, the protein A column was 
switched on-line to elute the IgG. Samples of each retained 
and nonretained fraction from injections of normal serum were 
collected for later analysis. 
Electrophoresis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed on 10% discontinuous vertical slab 
gels at pH 8.8, using a previously-published procedure (105). 
Samples of 50 to 150 pL were applied, using HSA and human IgG 
as the electrophoretic standards. The gels were stained with 
Coomassie Blue and analyzed with a scanning densitometer. 
Radial immunodiffusion 
SRID was performed as described earlier (106), using 1.5 
mm gels and 2 mm sample wells. The gels contained 1% agarose 
in 0.01 M phosphate buffer (pH 7.4), along with 0.85% sodium 
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chloride, 0.02% sodium azide, and 2% PEG. The gels also 
contained 0.2 to 1.6 jig/cm^ of affinity-purified goat anti­
bodies against either human IgG, IgA, or IgM. The chromato­
graphic fractions applied were preconcentrated 5- to 30-fold 
on Minicon B-15 clinical sample concentrators (Amicon, 
Danvers, MA). After development, the gels were stained with 
Coomassie Blue. 
99 
RESULTS AND DISCUSSION 
Static Properties of Protein A and Anti-HSA Supports 
The static properties obtained for the protein A and 
anti-HSA supports are given in Table V. The protein A SI 500 
results were essentially the same as those given in Section I 
under the same immobilization conditions. The immobilization 
yield for protein A was 86 ± 8%, and the resulting specific 
activity was 17% of the initial value claimed by the manufac­
turer. This rather low specific activity also agrees with the 
findings presented in Section I. As discussed in the pre­
ceding section, this low activity may be due to such effects 
as denaturation or improper orientation of protein A on the 
matrix as a result of the immobilization process. 
The anti-HSA support had an immobilization yield of 43%. 
This low yield was probably a result of the SI 4000 being 
saturated with immobilized protein, since the coverage was 
calculated to be approximately 1.0 monolayers based on a 
Stoke's diameter for IgG of 100 X (107). This was also 
suggested by the fact that when the same immobilization 
conditions were used with a higher surface area support, such 
as LiChrospher SI 500, virtually 100% of the protein in the 
antiserum was immobilized. 
Table V. Properties of protein A and anti-HSA supports 
Support 
Protein 
immobilized 
(mg/g silica) 
Static 
capacity 
(mg/g silica) 
Specific 
activity 
(mg/mg) 
Split-peak 
constant® 
( s )  
Protein A 
SI 500 
8.6 + 0.8 17.7 + 0.5 2.1 + 0.2 1.69 
Anti-HSA 
SI 4000 
16.5 + 1.1 0.90 ± 0.08 (5.5 ± 0.6) 
X 10-2 
< 2.8 
®The slopes given for the protein A and anti-HSA supports are for sample 
loads of 2 and 20% of the maximum static capacities, respectively. 
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The specific activity of the anti-HSA support, as 
determined by breakthrough analysis, was 72% of the initial 
value predicted by immunoprecipitation, assuming a maximum 
binding capacity of two HSA molecules per antibody. This 
indicated that relatively little anti-HSA activity was lost 
during the immobilization process. 
Elution Profiles of IgG and HSA as a Function of pH 
The conditions required for elution of human IgG and HSA 
from the affinity supports were determined for a pH elution 
scheme. The results are shown in Figure 10. For human IgG, 
all of the retained analyte was found to elute from the 
protein A SI 500 over a pH range of 7.0 to 3.6. This is in 
agreement with previous experimental results (50). Part of 
the reason for the broadness of this elution range was 
revealed by taking the derivative of the curve with respect to 
pH, giving the pH elution profile. When this was done, two 
major peaks were found to be present in the profile: the 
largest with a maximum in the elution profile at approximately 
pH 4.5, and a slightly smaller peak with a maximum at about pH 
4.9. These results agree with those obtained by Ohlson for 
human IgG on protein A SI 4000 (100) and Duhamel et al. for 
human IgG on protein A Sepharose (108). In these earlier 
studies, the peak at the lower pH was identified as IgG^ and 
Figure 10. Total percent of human IgG eluted from protein A 
SI 500 (0) and HSÂ eluted from antl-HSA SI 4000 
(H) as a function of pH 
103 
100 
350 
LU 
h-
5 
pH 
104 
the other as IgG^ (100,108). Because there ^were at least two 
independently eluting species present, the result was that the 
pH range needed for total sample elution was broadened, as was 
seen in Figure 10. Another contributing factor to broadening 
of the pH elution range may have been heterogeneity of the 
immobilized protein A, as discussed in Section I. 
A much narrower pH range was needed to elute HSA from the 
anti-HSA support. Figure 10 shows that all of the HSA was 
eluted from the anti-HSA SI 4000 between pH 4.5 and 3,0. The 
first derivative with respect to pH of the curve gave an 
elution profile consisting of one peak, which had a maximum 
between pH 3.8 and 3.6. The pH range of this profile is the 
same as that of the N-F transition of serum albumin, during 
which the protein undergoes a reversible conformational change 
(109). This suggests that such a transition might be the 
mechanism by which this analyte-ligand complex dissociates. 
In comparing the human IgG and HSA curves in Figure 10, 
significant overlap of the two was found to occur, particu­
larly in the pH range of 4.5 to 3.5. The maximum difference 
in the two curves was 68% at pH 4.1, where 18% of the HSA and 
86% of the human IgG were eluted. Since the number of moles 
of HSA in serum is typically nine times greater than that of 
IgG, it was concluded that this difference was not sufficient 
to resolve these two components quantitatively on an anti-
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HSA/protein A dual column system, especially if done only by 
means of either a series of pH step changes or a pH gradient. 
Selection of Operating Conditions 
Because a pH step change or pH gradient elution scheme 
alone was found to be insufficient to totally resolve IgG and 
HSA on this system, an alternative elution method had to be 
found. The technique used was based on a column-switching 
system, such as shown in Figure 11, allowing the IgG and HSA 
to be eluted independently from one another. In a typical 
analysis, this switching system was used by first injecting 
sample into the pH 7.0 application buffer with both columns 
on-line (a). This allowed the sample to pass through both 
columns and the HSA and IgG to be adsorbed. Once the non-
retained peak was eluted, the protein A column was switched 
off-line (b) and pH 3.0 buffer was applied to elute the HSA. 
The protein A column was later switched back on-line to elute 
the IgG (a). Finally, pH 7.0 buffer was again applied and the 
cycle repeated. Using this system, it was possible to adjust 
the resolution between the IgG and HSA peaks to any desired 
value by changing the time at which the protein A column was 
brought back on-line. 
An advantage of this system was that, by having the 
sample pass through the anti-HSA column first, it was possible 
Figure 11. Column-switching system for the protein A/anti-HSA 
system. The diagram shows the system with both 
the anti-HSA and protein A columns on-line (a) and 
with only the anti-HSA column on-line (b) 
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to reduce interferences in the IgG determination due to HSA 
adsorption on protein A. This was of concern since in * 
previous studies it was shown that protein A binds to porcine, 
canine, and feline albumin (110). To test for adsorption of 
human albumin on protein A, injections of normal serum were 
made into a 10 cm x 4.1 mm I.D. protein A SI 500 column, and 
the retained fractions collected. SDS-PAGE was then performed 
on these fractions. Three bands were seen in the retained 
sample. The two major bands corresponded to those for the H 
and L chains of an IgG standard and the third matched that 
produced by an HSA standard. Integration of the areas under 
each band with a scanning densitometer revealed that up to 9% 
of the total area was in the HSA band of the sample (55). 
This indicated that a significant amount of HSA had been 
adsorbed on the protein A column. By placing the anti-HSA 
column first in the dual-column system, an attempt was made to 
minimize this effect by removing any HSA present before the 
sample passed through the protein A column. 
Once the elution scheme and column order had been 
decided, it was necessary to determine the column sizes needed 
to retain IgG and HSA quantitatively under normal operating 
conditions. Two parameters were considered in determining 
this: the binding capacity of the supports and their adsorp­
tion kinetics. The kinetic properties of the supports were 
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particularly of interest, since this has not only been shown 
to be a limiting factor in analyte retention for protein A, as 
demonstrated in Section I, but also for a number of immuno-
affinity HPAC supports (28,34,37,39). This parameter was 
examined using the split-peak method. The values of the 
split-peak constant (C) obtained for these supports are given 
in Table V. 
In determining the required column sizes, a flowrate of 
1.0 mL/min and a sample size of 30 pg IgG and 100 pg HSA 
(i.e., a 10 pL injection of a 1:5 dilution of normal serum) 
were assumed to be typical operating conditions. The column 
volume needed to giye a column capacity equal to the sample 
load was determined from the static capacity values in 
Table V. The minimum value of Vcol required by the adsorp­
tion kinetics was calculated from Equation 36, using the 
values of C in Table V, the given flowrate, and assuming 99% 
retention (i.e., f = 0.01). 
The results are summarized in Table VI. For the protein 
A matrix, the minimum value of required to give a 
sufficient sample binding capacity was only 4.5 pL. However, 
the minimum value of Vcol needed to kinetically adsorb the IgG 
was about 30 times this value, or 130 pL, making adsorption 
kinetics the limiting factor in determining column size for 
this matrix. For the anti-HSA support, the static capacity 
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Table VI. Column size requirements for anti-HSA and protein A 
supports 
Support 
Minimum column volume (pL) 
Static requirement® Kinetic requirement^ 
Protein A 4.5 130 
SI 500 
Anti-HSA 230 < 220 
SI 4000 
&Based on a sample composed of 30 pg IgG and 100 pg HSA. 
The results were calculated from the static capacity data in 
Table V using packing densities of 0.38 g/mL for SI 500 and 
0.49 g/mL for SI 4000. 
^Based'on a flowrate of 1.0 mL/min, the split-peak 
kinetic data in Table V, and a minimum retention of 99%. 
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terra was slightly larger than that estimated for the adsorp­
tion kinetics, making the binding capacity the limiting 
factor. In this case, a minimum column volume of 230 pL was 
calculated for the anti-HSA matrix. To allow for more 
concentrated samples than assumed here, such as might occur 
when abnormal serum is tested, column volumes of 160 pL for 
the protein A and 530 pL for the anti-HSA were actually used 
(i.e., column sizes of 12.4 mm x 4.1 mm I,D. and 40.4 mm x 4.1 
ram I.D., respectively). 
This systera was tested, and the cycle time optimized, by 
injecting standards containing 80 pg HSA and/or 20 pg human 
IgG. Some typical chromatograras obtained are shown in Figure 
12. Injection of HSA (a) gave a single retained peak which 
was eluted from the anti-HSA column, and injection of IgG (b) 
gave a single retained peak which eluted from the protein A 
column. A sample containing HSA and IgG (c) gave a chromat-
ogram that was essentially the same as the sum of those 
obtained with the HSA and IgG standards. By using the elution 
times and peak widths obtained with these standards, as well 
as the void times for the system and the time required to 
switch from one buffer to another, a total cycle time of 6.0 
min for the separation was obtained, using the event sequence 
given in Figure 12. Under these conditions, the resolution 
(Rs) between the HSA and IgG peaks was 1.0. By delaying the 
Figure 12. Chromatograms obtained after injections of HSA 
(a), IgG (b), HSA plus IgG (c), and normal serum 
(d) into the dual-column system. The event 
sequence used was as follows: 0.00 min, switch 
from pH 3 to 7 buffer; 0.50 min, sample injec­
tion; 2.25 min, protein A column switched off­
line, switch to pH 3 buffer; 4.00 rain, protein A 
column switched on-line. The samples and 
chromatographic conditions used were the same as 
described in the text. The small peak at 1.4 min 
in (a-c) was due to the solvent change from pH 7 
to 3 plus IgGg in (b-c) 
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time at which the protein A column was brought back on-line, 
it was possible to obtain baseline resolution (i.e., Rs > 1.5) 
in a cycle time of less than 7.0 min. 
Using this elution scheme, the HSA peaks obtained were 
typically broader than those for IgG. An attempt was made to 
reduce the HSA peak width by using more acidic elution condi­
tions. By going to pH 2.0, it was possible to decrease the 
HSA peak width by 50% and the IgG—peak width by 20%. At this 
pH, however, the total cycle time actually increased, since at 
pH 2.6 the time required to regenerate the protein A column 
with pH 7.0 buffer became longer than the value of 30 seconds 
required at an elution pH of 3.0. Because of this effect, the 
elution pH was kept at 3.0 in order to minimize the cycle time 
while allowing both HSA and IgG to be quantitatively eluted. 
Quantitation of HSA and IgG in Serum 
Injections of a series of protein standards, containing 
20 to 140 fig HSA or 5 to 40 pg of human IgG, were used to 
calibrate the system. These standards covered the expected 
range of 70 to 104 pg HSA and of 14 to 34 pg IgG for a 10 pL 
sample of a 1:5 dilution of normal serum. The event sequence 
used was chosen to give a value for Rs ^ 1.5 between the HSA 
and IgG peaks so that both peak heights and areas could be 
determined. The responses were linear up to 100 pg for IgG 
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and 140 |ig for HSA. Correlation coefficients of 0.996 to 
0.997 over 7 to 9 points were obtained for all of the calibra­
tion curves. From these curves, the limit of detection for 
IgG at a signal-to-noise ratio (S/N) of 3 was estimated to be 
0.68 |ig when either peak height or peak area measurements were 
used. For a 1:5 dilution of a serum sample, this is equiv­
alent to an initial serum concentration of 0.34 g/L. The 
limit of detection at a S/N of 3 for HSA was 2.6 pg using 
peak heights and 3.5 pg using peak areas, corresponding to 
initial serum concentrations of 1.3 to 1.8 g/L, respectively. 
A series of injections of control sera, diluted 1:5 with 
pH 7.0 buffer was next made. A sample chromatogram is shown 
in Figure 12(d). The results are shown in Tables VII and VIII 
for serum samples containing normal and abnormal levels of IgG 
and HSA. The data given are the average of 7 to 8 serum 
injections for IgG and 3 to 5 injections for HSA. No signif­
icant difference was noted for either IgG or HSA when com­
paring the peak area and peak height results. As has been 
noted previously, the results obtained for IgG with this 
method agreed well with those of commercial SRID (27) and 
nephelometric assays. All experimental values were within one 
standard deviation of the range of control values given by the 
manufacturer. Similar agreement was found between the experi­
mental values for HSA and the control values from commercially 
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Table VII. IgG results for control serum samples 
Sample Peak height 
results 
IgG concentration (g/L) 
Peak area 
results 
Reference 
values® 
Normal 
control 
serum 
9.5 ± 0.6 9.7 + 0.2 
8.6 + 0.3 
to 
9.3 + 0.4 
Abnormal 
control 
serum 
5.6 + 0.2 5.8 + 0.5 
5.4 + 0.3 
to 
5.7 + 0.4 
*The reference values given are 
values provided by the manufacturer. 
the low and high assay 
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Table VIII. HSA results for control serum samples 
HSA concentration (g/L) 
Sample Peak height Peak area Reference 
results results values® 
Normal 
+
1 o
 3 
control A3 + 1 47 + 1 to 
serum 
+
1 
4 
Abnormal 21 + 3 
control 26 + 2 26 + 2 to 
serum 27 ± 2 
&The reference values given are the low and high assay-
values provided by the manufacturer. 
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available spectrophotoraetric and colorimetric dye-binding 
assays. The precision of the HSA and ZgG experimental results 
was also comparable to that of the control methods. For 
instance, the HSA peak height and peak area results gave 
average precisions of 4.7% and 4.6% (one relative standard 
deviation) for the two samples tested, while the commercial 
methods had a range of 1.8% to 6.3%. The IgG peak height and 
peak area results had average precisions of 4.5% and 5.1%, 
compared to values of 3.7% to 11.9% obtained with the other 
methods. 
The reproducibility of the results obtained with this 
system was examined using a series of 45 injections of normal 
control serum. The heights and areas of the HSA peaks were 
found to vary by ± 4.0% and ± 3.4%, respectively, while the 
heights and areas of the IgG peaks varied by + 2.6% and 
+. 3.6%, respectively. 
A similar set of injections was used to determine the 
lifetime of the system. No signs of column deterioration 
(e.g., abnormally-shaped peaks, increasing/decreasing peak 
heights or peak areas) were observed in over 120 injections 
into the anti-HSA column. These injections included 60 
standard samples and 60 serum samples. This is a much longer 
lifetime than the typical 20 to 25 column cycles reported for 
similar high-performance immunoaffinity matrices under acidic 
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elution conditions (54). This is probably a result of the 
fact that only a mildly acidic elution buffer of pH 3.0 was 
used here instead of a pH of 2.0 to 1.0, as commonly used with 
such matrices (54). The protein A column showed no signs of 
deterioration after more than 170 injections, including 60 
standards and 110 serum samples. This indicates that the 
immobilized protein A was very stable, as has been noted 
previously (27). 
The protein A and anti-HSA matrices, prior to packing, 
were also found to be quite stable. For example, when stored 
in pH 7.0 buffer at 4 °C, the protein A matrix showed no 
change in its characteristics over a period of at least 18 
months and the anti-HSA matrix over a period of at least 6 
months. 
The purities of the IgG and HSA peaks were examined by 
SDS-PAGE. Using injections of normal serum, only one band was 
observed in the fraction eluted from the anti-HSA column. 
This was identical to that given by an HSA standard. The 
fraction eluted from the protein A column contained two bands. 
These matched the bands for the H and L chains of a human IgG 
standard. Analysis of the gels by scanning densitometry 
showed no detectable amount (i.e., less than 0.5% of the total 
area) of IgG in the HSA peak or HSA in the IgG peak. Also, no 
other bands in either fraction were detected, with more than 
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99% of the integrated densitometer scans being due to HSA in 
the HSA peak and the H and L bands in the IgG peak. 
SDS-PAGE of the nonretained normal serum fraction showed 
that no detectable amount of HSA (i.e., less than 0.5% of the 
total HSA collected) was present. The relative amount of IgG 
in the nonretained peak was determined to be 8% by SRID. This 
agrees with the typical IgGg levels in normal serum of 5 to 9% 
(101). 
The levels of IgM and IgA in the IgG and nonretained 
peaks were also determined by SRID. These were of interest 
since IgM and IgA have the ability to bind protein A (50), 
making them possible interferences in the determination of 
IgG. From the SRID results, more than 95% of both the IgM and 
IgA was found to be eluted in the nonretained peak. These 
levels agree with those obtained previously on a similar 
protein A HFAC system (100). However, these levels are much 
greater than would be predicted based on the IgM and IgA 
levels of 66% and 30%, respectively, that are capable of 
binding to protein A (50). A possible explanation for this 
difference is that IgA and IgM may have exhibited a split-peak 
effect on the protein A matrix, similar to that seen for IgG . 
but with slower adsorption kinetics. This slower adsorption 
could be the result of the larger size (98) and slower 
diffusional properties of IgM and IgA compared to IgG, or the 
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fact that IgM and IgA may have a different mechanism 
binding to protein A than IgG (50). 
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CONCLUSIONS 
Several parameters were considered in the design of the 
HFAC system developed in this experiment. These included the 
static and kinetic properties of the supports as well as the 
elution conditions required for each analyte. The kinetic 
properties were evaluated using a modified version of Equation 
26, which allowed the adsorption kinetics of each support to 
be described by a single constant. This constant was then 
used to calculate the column size required by each support to 
produce the desired degree of retention at a given flowrate. 
By considering this along with the binding capacity of each 
support, the minimum column size required to quantitatively 
retain analyte on each matrix was determined. For the protein 
A support, column size was limited by the rate of immuno­
globulin adsorption, while the column size of the anti-HSA 
matrix was mainly limited by the static capacity. In 
considering both factors, a separation was obtained in which 
no significant amount of HSA or IgG, other than the expected 
level of IgGg, was nonretained. This was demonstrated by 
electrophoresis and SRID. 
The data presented show that this system was effective in 
selectively quantitating IgG and HSA in serum, giving results 
for both normal and abnormal samples comparable to those 
obtained with commercial methods. One potential advantage of 
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this method over other techniques is its speed of analysis, 
with the determination of both IgG and HSA being possible in 
only 6.0 min. In comparison, the time required for an equiv­
alent analysis by electrophoresis or immunodiffusion is on the 
order of hours or days. Another advantage of this method is 
its small sample requirement, with only 2 pL of serum being 
needed per injection. The selectivity of the system also 
makes it subject to fewer interferences than are encountered 
with the usual electrophoretic and spectrophotometric tech­
niques (97). Moreover, this method can be easily automated. 
This can be accomplished by using a system such as described 
in Reference 54 with the addition of an automatic valve for 
column selection. All of these characteristics suggest that 
this method should be useful for the rapid, routine analysis 
or screening of serum samples. 
Another advantage of this method is that the ratio of 
HSA/IgG in a sample can be obtained without prior calibration 
of the system. This can be calculated by using the absorp-
tivities of IgG and HSA at the detection wavelength along with 
their peak areas. This is analogous to the determination of 
the albumin/globulin ratio (98). Such ratios have the advan­
tage of being more sensitive than absolute measurements in 
detecting diseases where the level of one component increases 
and another decreases. For example, the HSA/IgG ratio should 
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be especially useful in the diagnosis of liver disease and 
chronic infections, where HSA levels are typically decreased 
and IgG levels increased (98). 
One possible limitation of this separation scheme is 
that, g^nce IgGg appears to be nonretained, differences in the 
relative IgGg content of the samples and standards can give 
rise to slight errors in the IgG determination. This can be 
minimized by using IgG standards prepared from pooled human 
serum, such as has been recommended for use with other immuno­
globulin assays (111), in order to obtain standards with 
average IgGg levels. Alternatively, anti-human IgG antibodies 
could be used in place of protein A as the affinity ligand. 
The effect of several potential interferences for this 
method were examined. Two of these were IgM and IgA, possible 
contaminants in the IgG determination due to their ability to 
bind to protein A. However, they did not interfere in this 
method since more than 95% of both components were eluted in 
the nonretained peak, possibly as a result of slow adsorption 
kinetics. Another interference studied was HSA, also a 
contaminant in the IgG determination due to its adsorption on 
protein A columns. This interference was removed by placing 
the anti-HSA column first in the system, a method which was 
shown to remove all of the HSA before it reached the protein A 
column. This demonstrates the potential usefulness of 
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affinity columns in removing undesirable sample components, a 
technique referred to as negative affinity chromatography 
(112), in analytical applications of HPAC or HFLC. 
As previously discussed, this dual-column system was not 
only effective in removing HSA as a contaminant, but was also 
useful in determining sample levels of both HSA and IgG. The 
use of such multicolumn or multidimensional systems has 
several potential advantages for chromatography in general 
(113). This technique is particularly promising for HPAC, 
since one of the disadvantages of affinity chromatography is 
that it can normally be used to detect only one or a few 
similar components at a time. The multicolumn approach given 
here is one way in which this limitation can be overcome, 
allowing several different analytes to be determined with the 
same system. 
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SECTION 
NONLINEAR ELUTION EFFECTS IN 
III. 
SPLIT-PEAK CHROMATOGRAPHY 
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INTRODUCTION 
The last two sections have demonstrated how the split-
peak method can be used in a number of practical applications. 
Examples have included the optimization of the adsorption 
kinetics of affinity columns and the comparison of the 
kinetic properties of affinity matrices. In both studies. 
Equation 26 was used as the basis for examining the kinetics 
of adsorption. As mentioned previously, the derivation of 
this equation is based on a number of assumptions, one of 
which is that the split-peak measurements are made under 
linear elution conditions. In other words, it is assumed 
that the relative size of the nonretained and retained peaks 
are independent of sample size. However, it was found in 
Section I that this is not the case for the IgG-protein A 
system. To better understand the reasons for this, the goal 
of this study was to examine the effect of nonlinear elution 
conditions on the relative size of the nonretained peak and to 
determine ways in which this effect might be controlled. 
In general, the effect of nonlinear elution conditions, 
or column overloading, has long been of interest in chroma­
tography. This has been true in both analytical and 
preparative-scale work, since such conditions may not only 
result in changes in column capacity, but can also affect 
solute retention (114-117), band-broadening (114-116), and 
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resolution (118)• A number of studies have been performed to 
better understand these effects and to develop methods by 
which they can be quantitated. Due to the complexity of the 
systems and calculations involved, computer simulations are 
often used in such studies (114,115,119,120). 
Nonlinear effects in split-peak chromatography are 
typically seen as an increase in the relative size of the non-
retained fraction with sample load. This has been observed 
with several affinity systems. These include not only the 
adsorption of IgG on protein A columns, but also the binding 
of IgG (34), insulin (34,39), and interferon (37) on immuno-
affinity columns. However, this dependence has not been 
observed for IgG retention on reversed-phase columns, as shown 
in Section I. 
It has already been mentioned that in some applications, 
such as the comparision of the split-peak slopes of affinity 
matrices or the optimization of column adsorption conditions, 
it may be possible to deal with these effects by standard­
ization of the column size and load conditions. This was the 
approach used for these applications in the previous two 
studies. However, in more fundamental work, such as the 
determination of adsorption rate constants, this approach is 
no longer sufficient if accurate results are to be obtained. 
Instead, techniques and guidelines are needed to minimize 
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or eliminate nonlinear effects so that results independent 
of sample size can be obtained. 
In this experiment, the effect of nonlinear elution 
conditions on split-peak measurements was studied using 
computer simulations. The two chromatographic cases examined 
were those in which the overall adsorption kinetics were 
either diffusion- or adsorption-limited. These are the two 
most useful cases for the determination of rate constants. 
Using simulations, guidelines were developed for minimizing 
nonlinear effects in both cases. The simulation results were 
then compared to data obtained for two experimental systems; 
the retention of IgG on protein A columns and the adsorption 
of hemoglobin on reversed-phase columns. 
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THEORY 
Computer Model 
The computer model used was the same as presented earlier 
(65). In this model, the column is divided into a large 
number of slices, each of which is further divided into three 
distinct regions: the flowing mobile phase, the stagnant 
mobile phase, and the stationary phase. All material injected 
on the column begins in the flowing mobile phase of the first 
slice. The simulation is performed by repeatedly carrying out 
two alternating operations. In the first, the material in 
each slice is distributed between the three phases according 
to the given set of kinetic equations and rate constants 
describing the system of interest. This is done for one unit 
of time, or one iteration. Once this has been done throughout 
the column, the material in the flowing mobile phase of each 
slice is shifted down the column one unit in order to simulate 
flow or convective mass transfer. At the same time, the 
amount of material leaving the last slice of the column is 
monitored, corresponding to detection of the chromatographic 
peak. This process is repeated until all but a given 
fraction of solute has eluted from the column, in this case 
all but 1 ppm of the remaining free analyte. 
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Two effects not directly considered by this model are 
extracolumn band-broadening prior to the column and band-
broadening within the excluded volume of the column. One 
cause of the first is the use of large sample loops. This is 
an important consideration in split-peak chromatography, since 
in both this work and related studies (121) injection volumes 
approaching or exceeding the excluded volume of the column 
have been used. Although this is not a problem under linear 
elution conditions, as was shown in Section I, it can 
potentially affect split-peak measurements made under non­
linear conditions. This effect can be studied in simulations 
by changing the number of iterations over which a given sample 
is applied. 
Band-broadening within the excluded volume of the column 
can occur by such processes as eddy diffusion or longitudinal 
diffusion. Although such an effect is not easily studied with 
this model, its role is probably not large compared to 
extracolumn band-broadening or other effects, especially when 
considering the relatively short column residence time of the 
nonretained peak and the small columns that have thus far 
been used in split-peak measurements. 
In order to compare the simulation results under non­
linear elution conditions to those predicted under linear 
conditions. Equation 23 was used. 
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-1 Ue 1 k-l 
= ( + ) (23) 
In f h kl kl kg [L] 
As given earlier, Ug is the linear velocity of an excluded, 
nonretained solute, h is the column length, and [L] is the 
initial concentration of ligand in the column, mL/Vp, Like 
Equation 26, the above expression predicts a linear rela­
tionship between -1/ln f and a term related to the column 
residence time of the analyte, Ue/h. Also as in Equation 26, 
the slope is comprised of two terras; the first, 1/ki, being 
related to the kinetics of mass transfer or diffusion, and the 
second, (k_i/ki kg [L]), being a function of the system's 
adsorption kinetics. Using Equation 23, it is possible to 
calculate the theoretical value of -1/ln f under linear 
elution conditions given Ug/h, [L], and the rate constants of 
the system. This equation is particularly useful in simula­
tions of the type done here since the total residence time of 
analyte in the column can be varied by changing the column 
length h (i.e., the number of slices in the column) while 
keeping Ug and the reaction time in each slice constant (i.e., 
an excluded linear velocity of one slice/iteration and a 
reaction time of one iteration). 
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Equations for Diffusion-Limited Kinetics 
Two cases were considered in looking at nonlinear elution 
effects: mass transfer- or diffusion-limited kinetics, and 
adsorption-limited kinetics. The first case studied was that 
of simple diffusion-limited kinetics with irreversible adsorp­
tion. In this case, adsorption is assumed to be much faster 
than mass transfer, or kg >> k_i, such that any solute 
entering the stagnant mobile phase binds to free ligand rather 
than diffusing back to the flowing mobile phase. The effect 
on Equation 23 as adsorption becomes infinitely fast (i.e., kg 
approaches infinity) is that the second slope term, 
(k-i/ki k3 [L]), becomes much smaller than the first. This 
reduces Equation 23 to 
-1 Ug 1 
In f h kl 
which is an expression equivalent to that given in Equation 
27. Equation 37 predicts that for the diffusion-limited case 
under linear elution conditions, a plot of -1/ln f vs. Ug/h ki 
should yield a line with a slope of one and an intercept of 
zero. 
The results for this case under nonlinear conditions can 
be obtained by representing the system by the following 
reactions : 
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kl 
E e  s  E  ( 3 8 )  
k-i 
Fast 
E p  +  L  >  E p - L  ( 3 9 )  
As given previously. Eg and Ep represent the free analyte in 
the flowing and stagnant mobile phases, respectively, and L 
represents the free ligand remaining in the column. Unlike 
the system used previously, however, this system no longer 
considers [L] or m^ to be constant. In other words, linear 
elution conditions are no longer assumed to be present. 
Note in these reactions for the diffusion-limited case 
that two situations may occur. The first takes place when 
free L is present in the stagnant mobile phase. In this 
situation, any E diffusing into the stagnant mobile phase 
immediately binds to ligand, preventing E from diffusing back 
to the flowing mobile phase. The net reaction of Equations 3 8  
and 39 under these conditions can be written as 
kl 
E e  >  E p - L  ( 4 0 )  
This can be described by the integrated rate expression for a 
simple first-order reaction (122) 
-k-, t 
mEes = ""Eeso® (*1) 
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where t is the time of reaction, and mp and rag are the 
^es eso 
moles of Eg present at times t and 0. The subscript "s" is 
used here to refer to the fact that these parameters are those 
for the particular slice studied during a given iteration. 
The second situation which can occur takes place when all 
free L in the slice has been depleted, so that E is no longer 
able to adsorb onto the stationary phase in that region. The 
result is that E can only undergo diffusion into and out of 
the pores of the support, making the net reaction 
ki 
EE ^  EP (42)  
k.i 
This reaction can be described by the integrated rate 
expression for a reversible first-order reaction (122) 
mp = mp +  (mp ~  )  e ^  ^ -1^ ^  (43) 
^es ^esoo &eso ^es» • 
where mp is the moles of E present at equilibrium in the 
e^soo 
flowing mobile phase of the slice of interest. 
The point at which the system switches from the situation 
given in Equation 40 to that in Equation 42 occurs when enough 
solute has entered the stagnant mobile phase to totally bind 
any free ligand present. The reaction conditions required for 
this can be determined by using Equation 41 and the mass 
balance expressions for the system, giving the equation 
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MLso = ®Eeso (1 - G (44) 
which gives the time and mole conditions at which all free L 
is depleted. If the reaction conditions are such that mLgg is 
greater than or equal to the right-hand side of Equation 44, 
then the system can be described by Equation 41. If mLgq is 
less than this expression. Equation 41 is used until all 
ligand in the slice has been depleted and then Equation 43 is 
used to describe the system. 
Equations for Adsorption-Limited Kinetics 
The second case studied was that of simple, irreversible 
adsorption-limited kinetics. In this case, diffusion is 
assumed to be much faster than adsorption (i.e., and k_% >> 
kg) giving rise to an equilibrium in mass transfer of solute 
between the stagnant and flowing mobile phases. The effect on 
Equation 23 is that its diffusional slope term, 1/k^, becomes 
small vs. that for adsorption, reducing Equation 23 to 
-1 Ug k_i 
= ( ) (45) 
In f h ki kg [L] 
The expected result, then, for the adsorption-limited case 
under linear elution conditions is that a plot of -1/ln f vs. 
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(ue/h)(k_i/ki kg [L]) will give a line with a slope of one and 
an intercept of zero. 
To calculate the results for this case under nonlinear 
conditions, the system is represented by the reactions 
Kl 
E e  ^  ^  E p  ( 4 6 )  
kg 
E p  +  L  ^  E p - L  ( 4 7 )  
Integrated rate expressions describing this system can be 
derived using an approach similar to that given for a one 
phase, second-order reaction in Reference 122. This is done 
by first writing the rate law expression for the reaction in 
Equation 47. 
-d [Llg 
=  kg [ E p ] g  [L] g  (48) 
dt 
In this equation, [Ep]g and [L]g are the concentrations of Ep 
and L in the stagnant mobile phase of the slice studied and 
all other terras are as defined previously. Converting 
Equation 48 to an expression in terms of moles gives 
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where Vpg is the pore volume per slice, Vp/h. The mass 
balance expression for this system can next be obtained by 
using the reaction stoichiometry given in Equation 46 and 47. 
( M E e s o  •  m E e g )  +  ( ^ 3 0  "  " E p g )  =  )  ( 5 0 )  
Since it is given that diffusion for this system is much 
faster than adsorption, or that mass transfer is in 
equilibrium, the ratio Vpg/Vgg may be substituted for 
•"Epg/^Ees Bccofding to Equation 3. By using this in Equation 
50 along with the fact that Vpg + Vgg is V^g, the total slice 
void volume, the mass balance expression in terms of mp can 
ps 
be written as 
™Eps " (mEggo + WEpgo - MLgo + ^^Ps/^ms) (51) 
This equation may be simplified by replacing (^Egg^ + rngpgo ~ 
m^gg) with a single constant, x. Substituting this into 
Equation 51 and combining Equations 51 and 49 results in the 
following differential equation: 
-d mL 
= (kg/V^g) dt (52) 
mig (x + mig) 
Depending on the value of x, two different solutions to 
Equation 52 may be obtained. For x / 0, integration of 
Equation 52 between times 0 and t yields 
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In = 
' 7^ '  *  'Xo  -  %so "  %so '  ' •^3 l \s '>  t  (53 )  
Epso 
For the case where x = 0, Equation 52 reduces to the following 
form: 
-d mL 
= (kg/Vms) dt (54) 
CmL^)2 
Integration of this expression between times 0 and t yields 
11 kg 
= + ( ) t (55) 
niLg Vms 
Thus, if the initial conditions in a slice during a given 
iteration are such that (mp + m, - mr ) is zero, &eso &pso ^so 
Equation 55 is used to describe the system. If (mr + m? 
*eso 'pso 
- mLgg) is not zero, then Equation 53 is used. 
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EXPERIMENTAL 
Reagents 
The protein A, rabbit IgG, and bovine hemoglobin were 
from Sigma (St. Louis, MO) and were the purest grades 
available. The morpholine and GDI were from Aldrich 
(Milwaukee, WI). The ji-octyldimethylchlorosilane was from 
Petrarch (Bristol, PA). The LiChrospher SI 500 (10 |im 
particle diameter, 500 A pore size) was obtained from Alltech 
(Deerfield, IL). 
Instrumentation 
The chromatographic and data acquisition systems were the 
same as described in Section I. The detector used for the IgG 
studies was a Hitachi 100-10 (Tokyo, Japan) operated at 280 
nm. For the hemoglobin studies, the detector was a Kratos 757 
(Ramsey, NJ) operated at 414 nm. Computer simulations were 
performed on a National Advanced Systems 9160 computer 
(Mountain View, CA). 
Procedures 
Computer simulations 
All simulations were performed in Fortran G using double-
precision logic. Listings of the programs used are given in 
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the Appendix. The simulations were initiated by placing the 
desired amount of material in the flowing mobile phase portion 
of the first slice and were ended when all but 1 ppm of the 
remaining nonadsorbed material had eluted off the column. 
Programs were tested for convergence by performing a 
series of equivalent simulations in which columns were divided 
into increasingly larger numbers of slices while the rate 
constants for the system were proportionately decreased. All 
values reported are within 20 ppm of the estimated value for a 
column divided into an infinite number of slices, as deter­
mined in this manner. 
Preparation of protein ^  and reversed-phase supports 
The LiChrospher reversed-phase support was prepared 
according to published procedures (83,86) using 5.0 g n-
octyldimethylchlorosilane/g silica and 50 g of carbon 
tetrachloride/g silica. 
The diol-bonded LiChrospher was also prepared as 
described previously (80). The diol coverage of the 
LiChrospher prior to activation was 200 pmol/g silica as 
determined by the periodate oxidation method (84,85). 
Protein A was immobilized onto the diol-bonded 
LiChrospher using the CDI method (81) described in Section I. 
Immobilization was performed at pH 4.0 using 10 mg protein A/g 
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silica. As determined in Section I, the immobilization yield 
of protein A under these conditions is approximately 100%. 
Chromatography 
The weak mobile phase for the reversed-phase matrix was 
0.02 M ammonium phosphate, 0.01% morpholine (v/v), (pH 7.0). 
All hemoglobin solutions were prepared in this buffer. The 
strong mobile phase was 2-propanol containing 0.01% 
morpholine. Protein retained on the reversed-phase support 
was eluted by using a linear 20 min gradient from 0 to 100% 2-
propanol at a flowrate of 0.25 mL/min. 
The application buffer for the protein A matrix was 0.10 
M potassium phosphate buffer (pH 7.0) and the elution buffer 
was 0.10 M potassium phosphate (pH 3.0). All IgG solutions 
were prepared in the pH 7.0 phosphate buffer. Elution of IgG 
adsorbed on the protein A was done by a step change in pH. 
Both the reversed-phase and protein A matrices were 
placed into their respective weak mobile phases and vacuum-
slurry packed (83) into columns of a previously-published 
design (79). 
Kinetic studies on these columns were performed at 25 °C. 
All other chromatography was performed at room temperature. 
Prior to the kinetic studies, both the protein A and 
reversed-phase columns were pretreated several times with 
either excess IgG or hemoglobin to remove any residual active 
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groups or irreversible adsorption sites. To test for the 
removal of such sites, the static capacity of each matrix was 
measured by integration of the resulting breakthrough curves 
(87) and correcting for the void volume of the system. The 
capacities were found to be 8.6 ± 0.4 mg IgG/g silica for the 
protein A matrix and 47.1 ± 0.4 mg hemoglobin/g silica for the 
reversed-phase matrix. The static capacities of the matrices 
were estimated to decrease by less than 5% over the course of 
the kinetic studies. 
The split-peak behavior of the matrices was studied using 
the method described in Section I. For the protein A, split-
peaks were obtained by injecting 10 pL of 0.14 to 0.55 mg/mL 
IgG on a 6.35 mm x 4.1 mm I.D. column at flowrates of 0.02 to 
0.5 mL/min. The areas of both the nonretained and retained 
peaks were determined by computer integration, normalized vs. 
flowrate, and corrected for any sample impurities (0.8% of the 
total IgG area) or background shifts present. The total 
corrected IgG area was found to be a linear function of sample 
size over the entire concentration range studied. These 
corrected areas were used to calculate the free fraction f as 
described in Section I. 
For the reversed-phase columns, split-peaks were observed 
by injecting 3 fiL of 0.5 to 2.0 mg/mL hemoglobin on a 6.35 mm 
X 1.0 mm I.D. column at flowrates of 0.06 to 0.63 mL/min. The 
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nonretained peak area was found as described above, normalized 
vs. flowrate, and corrected for the solvent background. No 
corrections for sample impurities, which were less than 0.2% 
of the total area, were made. The corrected area was found by 
injecting sample through an open tube and correcting for 
the solvent background. This total corrected area was found 
to vary linearly with sample size over the entire sample range 
studied. The free fraction was calculated by dividing the 
nonretained area by this total corrected area. 
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RESULTS AND DISCUSSION 
Simulations for Diffusion-Limited Kinetics 
In the first simulation study, the effect of nonlinear 
elution conditions in split-peak chromatography was examined 
for systems with diffusion-limited kinetics and irreversible 
adsorption. This was done by monitoring the relative size of 
the nonretained peak as a function of solute residence time 
and column load. In this and in all following studies, the 
column load was defined as or the ratio of the 
total moles of solute applied to the column to the moles of 
free ligand initially present. Also, reduced velocity param­
eters, such as Ug/h ki and (ug/h)(k_i/ki kg [L]), were used in 
all simulation studies to give results independent of the 
absolute values of the system rate constants. 
The normalized split-peak plots for this case are given 
in Figure 13 for loads of 16 to 128% of the column capacity. 
Each plot in Figure 13 is the best-fit curve through 27 data 
points distributed over the entire Ug/h k^ range shown. By 
plotting the data for this case as a function of the reduced 
velocity parameter Ug/h k%, the results were found to not only 
be independent of the absolute value of k%, but were also 
independent of the porosity term Vp/Vg (i.e., k^^ /k,^ ) over the 
range in Vp/Vg of 0.1 to 2.0. These Vp/Vg values include 
Figure 13, Normalized split-peak plots at various column 
loads for the case of diffusion-limited kinetics 
with irreversible adsorption. The plots given are 
for column loads of 16 to 128%, in intervals of 
16%. The line shown is the response predicted 
under linear elution conditions by Equation 37 
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those found with common chromatographic matrices (123,124). 
In testing for extracolumn effects, it was found that the data 
in Figure 13 were also independent of the injection volume 
over the load range of 1.6 to 128% and Ug/h ki values of at 
least 0.06 to 1.28, since no change in -1/ln f was noted under 
these conditions in going from an application volume of one 
slice to twice the excluded volume of the column. 
Under linear elution conditions, the.plots in Figure 13 
would be expected to give the linear relationship predicted by 
Equation 37. Under the nonlinear conditions used to generate 
the data, however, deviations from the ideal response were 
found to occur at all loads studied. In general, the simula­
tion values of -1/ln f were larger than or equal to those 
predicted, with the extent of the deviations increasing with 
column load. These deviations typically occurred when the 
value of Ug/h ki was small, or the residence time large, but 
disappeared as ue/h ki increased. Also, the range of Ug/h ki 
values over which deviations occurred increased in proportion 
to the column load applied. For instance, a load of 64% 
gave deviations up to a Ug/h k^ value of approximately 0.64 
while a load of 128% gave deviations up to a value of about 
1.28. 
It was further observed in Figure 13 that plots for loads 
of less than 100% appeared to have a zero intercept, while 
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those for loads of greater than 100% had an intercept greater 
than zero. This is due to the fact that as Ug/h k% approaches 
zero, or the solute residence time becomes infinitely long, 
the amount of sample adsorbed reaches its maximum value. When 
the sample applied is less than or equal to the column 
capacity, all would be expected to adsorb, causing -1/ln f to 
approach zero. If the load is larger than the column 
capacity, then the amount adsorbed approaches this capacity, 
leaving some free solute behind and giving -1/ln f a value 
greater than zero. 
As stated in Section I, an experimental system believed 
to exhibit diffusion-limited kinetics is the adsorption of 
some proteins on reversed-phase columns. One protein thought 
to show such behavior is hemoglobin (121). To compare this 
system to the simulation results presented, split-peak plots 
were made for injections of hemoglobin on a C8 reversed-phase 
column at known loads. The results are given in Figure 14 for 
loads of 1.7 and 6.8%. 
In order to compare the experimental results in Figure 14 
to the simulation data in Figure 13, it was necessary to 
determine what range of reduced velocities was represented by 
the data in Figure 14. This was done by making use of the 
linear region of the 0.50 mg/mL data, which occurred at 
flowrates of approximately 0.25 mL/min or greater. Since 
Figure 14. Split-peak plots for hemoglobin on a reversed-
phase column. The plots shown are for 3 pL injec­
tions of 0.50 mg/mL (#) and 2.00 mg/mL (•) 
bovine hemoglobin. The chromatographic conditions 
were the same as described in the text. The line 
shown is the linear fit for the 0.50 mg/mL data 
over a flowrate range of 0.25 to 0.63 mL/min 
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this region followed the relationship between residence time 
and -1/ln f predicted by Equation 37, it was used to represent 
the theoretical response of the system under linear elution 
conditions. A linear least-squares fit to the data in this 
range gave a slope of 1.48 +. 0.06 min/mL and an intercept of 
0.01 +. 0.03. By multiplying each flowrate in Figure 14 by 
this slope, it was determined that the experimental data shown 
represented a u^/h range of 0.09 to 0,93. 
Several similarities can be seen in Figures 13 and 14. 
For example, the data in Figure 14 show the same deviation 
patterns seen in Figure 13 in that the obtained values of 
-1/ln f are larger than predicted at long residence times, or 
slow flowrates, but approach the expected response for linear 
elution conditions as flowrate increases. Also, in both 
f-i-gures the size of the deviations and the flowrate range over 
which they occur increase with the load. Furthermore, this 
flowrate range again appears to increase roughly in proportion 
to the load, with the 0.50 mg/mL data showing nonideal effects 
up to a flowrate slightly over 0.2 mL/min and the 2.0 mg/mL 
data showing deviations up to a flowrate of approximately 0.8 
mL/min. 
Figures 13 and 14 differ in that the deviations in 
-1/ln f seen experimentally were larger than those predicted 
from the simulations. This can be due to a number of 
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secondary effects not taken into account by the kinetic model 
used. Such effects may include site heterogeneity, as dis­
cussed in Section I, and reversible binding (125). Site 
heterogeneity can be important for the diffusion-limited case 
if ligands with different mass transfer properties are 
present; such as those located at different depths within the 
matrix or on particles of different diameters. Under linear 
elution conditions, this results in becoming an apparent 
rate constant, or a function of the individual mass transfer 
rates present. This also occurs under nonlinear conditions 
but with the additional possibility that some types of sites 
may saturate before others. The result is a change in k^ and 
-1/ln f with sample load, giving greater deviations than would 
be expected for a simple homogeneous matrix. This can be 
illustrated by using the results given in Section I. In this 
previous chapter, it was found that the apparent k^ measured 
for IgG on reversed-phase supports of the same diameter 
decreased by 17-fold in going from a matrix resembling the 
simple homogeneous case, such as C8 Nucleosil SI 50 on which 
IgG could only access ligands near the surface of the 
particles, to a more heterogeneous support, such as C8 
LiChrospher SI 500 on which IgG could also sample ligands 
within the pores. This type of behavior makes site hetero­
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geneity a likely explanation for the differences noted between 
Figures 13 and 14. 
Reversible binding may be an important factor in split-
peak measurements if weakly-retained solute elutes near the 
nonretained peak, increasing the apparent free fraction and 
value of -1/ln f measured. In previous simulation studies, it 
was shown for linear elution conditions that this is a sig­
nificant problem only for systems with k*. values of 10 or less 
(125). Although deviations due to reversible binding may 
increase under nonlinear conditions, the fact that hemoglobin 
was estimated to have a k' over 1500 in this experiment 
suggests that this was not a major effect. 
Regardless of which secondary effects were present, the 
data in Figures 13 and 14 clearly show that nonlinear effects 
in split-peak chromatography under diffusion-limited condi­
tions can be minimized or even eliminated by choosing the 
proper load and/or flowrate. This helps explain why such 
effects were not seen earlier in work examining retention of 
IgG on reversed-phase columns, as presented in Section I. In 
this previous study, it was found that IgG adsorption on C8 
Nucleosil SI 50, which should have behaved similarly to the 
homogeneous case in Figure 13, gave no nonlinear effects over 
loads of 7.3 to 14.5% and a Ug/h k^ range of 0.13 to 0.36. A 
comparison of these values with those in Figure 13 shows that 
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no observable deviations would have been expected under these 
conditions. A similar study on C8 LiChrospher SI 500, per­
formed under the same chromatographic conditions used for the 
heterogeneous case in Figure 14, gave no nonlinear effects for 
loads of 2.4 to 4.0% and a Ug/h k% range of 0.24 to 0.94. 
Assuming IgG and hemoglobin behaved similarly on this matrix, 
a comparision of these values with those in Figure 14 
indicates that no significant deviations would have been 
expected for the data at 2.4% load or over the majority of 
this range for the 4.0% load data. The results in Figure 14 
do predict some observable deviations at the lower ue/h ki 
values for the 4.0% load, but the fact that these were not 
observed may be a result of differences in the response of IgG 
and hemoglobin to secondary effects. For example, IgG may 
have been less susceptible than hemoglobin to site hetero-
o 
geneity due to its larger size, a Stoke's diameter of 104 À 
for IgG vs. 62 S for hemoglobin (45,126), preventing it from 
sampling as many diffusionally-distinct ligands within the 
pores. 
The disappearance of deviations for the diffusion-limited 
case at small residence times or column loads was examined 
further by performing a second series of simulations in which 
the effect of increasing loads on -1/ln f was measured at 
constant values of Ug/h k^. This corresponds to an experiment 
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in which -1/ln f is determined at a constant flowrate while 
the sample load is varied. Figure 15 shows the results 
obtained at several Ug/h values. In Figure 15, the load is 
normalized vs. Ug/h to illustrate its relationship to this 
parameter as deviations begin to occur. The y-axis is also 
normalized vs. Ug/h but this is done only for ease of 
presentation. 
For each value of Ug/h k% monitored, the resulting plot 
showed no deviations from the expected response under linear 
conditions at small values of Load/(Ug/h k^) (i.e., small 
sample loads). But when this term exceeded 1.0, deviations in 
-1/ln f began to occur. It was also noted that the relative 
size of these deviations increased with the value of Ug/h k^ 
monitored. 
Based on the simulation and kinetl-c models used, an 
equation was derived to explain why the deviations in Figure 
15 began to occur at such a well-defined point. To do this, 
it was assumed that all deviations began in the first slice of 
the column during the first iteration, when the amount of free 
analyte was largest vs. that of free ligand. Under these 
conditions, the initial amount of free ligand present in the 
slice, i"LgQ' equal to Ng m^/h, where m^/h is the original 
amount of ligand per slice and Ng is the number of slices 
examined. Since only the first slice is considered in this 
Figure 15. The effect of increasing load on -1/ln f at a 
constant value of Ug/h . The plots shown are 
for Ue/h values of 0.16 (#), 0.32 C^), 0.64 
(A)f and 1.28 (fl). The horizontal line is the 
response predicted under linear elution conditions 
by Equation 37 
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case, Ng is equal to one slice. Also under these conditions, 
the initial amount of free analyte in the slice, mr , is 
eso 
equal to the total amount of analyte applied, or CLoad)(mL), 
using the definition of load given earlier. Furthermore, it 
is possible from the simulation model to replace the slice 
reaction time t by the quantity Ng/ug. Using these expres­
sions along with Equation 44 gives the following relationship; 
Load 1 [h (1 - e"^! ^ s/"e)/Ng]-l (56) 
This equation gives the range of loads that can be used at a 
given value of Ug/h before deviations begin to occur in a 
system composed of a finite number of slices. 
The equivalent expression for a real system, or one 
approaching an infinite number of slices, can be obtained by 
finding the limit of Equation 56 at a constant value of 
Ug/h by simultaneously increasing the number of slices in 
the column and decreasing the amount of time per slice or 
increasing Ug to keep the total residence time constant. As 
this is done, the exponential term of Equation 56, e ^s/^e^ 
approaches zero and may be replaced by (1 - ki Ng/ug), the 
first- and zeroth-order terms of its Taylor series expansion 
(127). Substitution of this into Equation 56 gives 
Load/(Ug/h k^) < 1 (57) 
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which is the same relationship noted empirically in Figure 15. 
This expression shows that either a small load or large value 
of Ug/h k2 minimizes deviations because both cause the ratio 
in Equation 57 to decrease. Equation 57 also explains why the 
range over which deviations appear is directly proportional to 
the load applied. This occurs since as larger loads are used, 
a proportionately larger value of Ug/h is needed to bring 
the ratio in Equation 57 back to a value of 1.0 or less. 
By combining Equation 57 with Equation 37, an alternate 
relationship is obtained for predicting when deviations occur 
even when the kinetic parameters of the system or the value of 
ug/h ki is not known. 
Load/(-l/ln f) < 1 (58) 
Thus, by measuring -1/ln f for a known sample load at the 
flowrate of interest and computing the above ratio, an 
estimate of whether or not nonlinear effects are occurring can 
be made for diffusion-limited systems following the model used 
here. If the ratio is greater than 1.0, deviations would be 
expected to occur. As the ratio becomes less than or equal to 
1.0, the chance of deviations occurring would be expected to 
greatly decrease. 
The hemoglobin data suggests that this ratio might also 
be useful in the study of more complex diffusion-limited 
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systems. This is indicated in Figure 14 by the fact that the 
flowrate at which deviations begin to occur appears to 
increase proportionately with the load. Based on the rela­
tionship between flowrate and -1/ln f given in Equation 27, 
this is equivalent to saying that deviations start to appear 
at a constant value of Load/(-l/ln f), in this case a ratio of 
0.05. Though this value is much less than that predicted by 
Equation 58, probably as a result of the presence of secondary 
effects in the hemoglobin studies, the fact that it appears to 
be constant still makes it useful in minimizing nonlinear 
effects. For example, if the exact ratio at which deviations 
start to occur is known, as it is here, then the flowrate 
conditions required to eliminate nonlinear effects at any size 
load can be determined. Even if this particular value is not 
known, the ratio Load/(-l/ln f) is useful in indicating 
whether nonlinear effects may be present, since nonlinear 
effects are less likely to occur as Load/(-l/ln f) decreases. 
In general, it is known from Equation 58 that conditions 
giving a ratio of less than or equal to 1.0 should always be 
used to avoid nonlinear effects, while the hemoglobin results 
further indicate that for complex diffusion-limited systems, 
such as those using porous supports, conditions giving a ratio 
even as low as 0.05 or less may be desirable. 
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Simulations for Adsorption-Limited Kinetics 
The second set of simulation studies examined nonlinear 
effects in split-peak chromatography for systems with irre­
versible adsorption-limited kinetics. The first series of 
simulations performed looked at the change in -1/ln f with 
increasing loads as a function of a reduced velocity param­
eter, (Ug/h)(k_i/ki kg [L]). 
The normalized split-peak plots obtained are shown in 
Figure 16 over the same range of reduced residence times and 
column loads as used in Figure 13. Each plot given is the 
best-fit curve through 13 to 16 data points distributed 
throughout the entire range shown. These plots were again 
found to be independent of Vp/Vg over the range of 0.1 to 2.0. 
It was also found based on the simulation model that varying 
the injection volume or extracolumn dispersion did affect the 
results slightly, with -1/ln f decreasing as the application 
volume increased. This was seen for each load studied, a 
range of 1.6 to 128%, over injection volumes ranging from one 
slice to twice the column excluded volume and a (ug/h) 
(k_i/ki k3 [L]) range of 0.06 to 1.28. However, this effect 
was not a major problem in this study since this decrease was 
negligible vs. the overall deviations seen in Figure 16, with 
the largest observed decrease being only 0.3 ppt of the total 
deviation measured and with the extent of the decrease 
Figure 16. Normalized split-peak plots at various column 
loads for the case of irreversible adsorption-
limited kinetics. The plots given are for column 
loads of 16 to 128%, in intervals of 16%. The 
line shown is the response predicted under linear 
elution conditions by Equation 45 
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becoming smaller as the simulated columns were divided into an 
increasing number of slices. 
In comparing the data in Figure 16 to the results 
predicted by Equation 45 under linear elution conditons, 
deviations were again seen for all loads studied. As noted in 
Figure 13, the simulations gave -1/ln f values larger than 
those predicted, with deviations increasing as load increased. 
It was also again seen that plots for loads of less than 100% 
appeared to have zero intercepts while those for loads above 
100% gave nonzero intercepts. This occurred for the same 
reasons as discussed previously. 
Despite the similarities between Figures 13 and 16, there 
were also significant differences. For example, the values of 
-1/ln f for the adsorption-limited case were typically greater 
than those for the diffusion-limited case under the same load 
and reduced residence time conditions. The two cases also 
differed in that the results in Figure 16 did not converge 
with the response predicted under linear elution conditions. 
Instead, no apparent decrease in absolute deviations was noted 
as (ue/h)(k_i/ki kg [L]) increased. This occurred for all 
loads studied and over a (ue/h)(k_i/ki kg [L]) range of at 
least 0.03 to 20 (i.e., an expected free fraction range under 
linear elution conditions of 3 x 10"^^% to 95%). It was 
further noted in Figure 16 that small loads, such as 16 and 
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32%, gave an almost linear increase in -1/ln f with (Ug/h) 
(k_i/ki kg [L]), behavior not noted in the diffusion-limited 
results. 
Differences in the adsorption- and diffusion-limited 
cases were also apparent when comparing their responses to 
increasing load at a constant residence time. The results for 
the adsorption-limited case, shown in Figure 17, differ from 
those under equivalent conditions for the diffusion-limited 
case in Figure 15 in that deviations were present at all loads 
and residence times studied while in the diffusion-limited 
case they occurred only once a certain load level had been 
reached. Also, it was again noted that the relative size of 
the deviations in the adsorption-limited case were larger than 
those for diffusion-limited systems under equivalent 
conditions. 
Such differences can be explained based on the two 
kinetic models used. In the case of diffusion-limited 
kinetics, the system is represented by a series of first-order 
reactions and, under linear elution conditions, the split-peak 
slope is independent of the number of ligand sites. The 
result, as shown earlier, is that deviations occur only after 
all ligand in the first segment of the column has been 
depleted. This produces the behavior seen in Figures 13 and 
and 15, where certain load and residence time conditions must 
Figure 17. The effect of increasing load on -1/ln f at a 
constant value of (ug/h)kg [L]). The 
plots shown are for (ug/h) (k_i/ki kg [L]) values 
of 0.16 (•), 0.32 (^), 0.64 (A)» and 1.28 (•). 
The horizontal line is the response predicted 
under linear elution conditions by Equation 45 
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be met to produce nonlinear effects. In the adsorption-
limited case, however, the model used is second-order in 
nature and the split-peak slope is a function of 1/[L]. This 
means that any depletion of free ligand will cause the 
apparent rate constant kg [L] to decrease and the split-peak 
slope to increase. As a result, the adsorption-limited case 
would be expected to be more susceptible to deviations than 
the diffusion-limited case at any given load, with deviations 
occurring as long as finite sample loads are used. 
In Section I it was shown that one experimental sys tem 
exhibiting adsorpt ion-limited kinetics is the binding of IgG 
to CDI-immobilized protein A affinity c olumns. Typical spli t-
peak plots for thi s system are given in Figure 18 for lo ads of 
0.9 to 3.7%. Thes e plots are similar t o the simulation 
results in Figure 16 in several ways. First, each data set in 
Figure 18 gave an apparent linear relat ionship between -1/ln f 
and flowrate, as s een for loads of 32% or less in Figure 16. 
Secondly, the IgG data at different loa ds did not conver ge t o 
a single response at high flowrates, as was also seen with the 
simulation results, but continued to increase with flowrate 
over the entire range studied. 
Because of this last factor, eliminating or even 
minimizing nonlinear effects for such a system can prove 
difficult if done by only adjusting the flowrate and/or load 
Figure 18. Split-peak plots for IgG on a CDI-immobilized 
protein A column. The plots shown are for 10 uL 
injections of 0.14 (#), 0.27 (A)» and 0.55 (|) 
mg/mL rabbit IgG. The chromatographic conditions 
were the same as described in the text. The line 
given for each data set is its linear fit through 
the origin 
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conditions. Instead, a technique is required to extrapolate 
the results under linear elution conditions from those 
obtained under nonlinear conditions. A third set of simula­
tion studies were performed to determine what extrapolation 
methods could be effectively used. The technique tested was 
one using linear extrapolation, since in Section I it was 
shown that the split-peak slope of such protein A columns 
appeared to increase linearly with sample load. 
These studies were done by using the simulation model to 
generate split-peak plots at various loads under adsorption-
limited conditions. The slope of each plot was then measured 
using a linear least-squares fit through the origin, the same 
technique used in the previous study. Each slope was measured 
using 14 points over (ug/h)(k_i/ki kg [L]) values of 0.063 to 
1.24. This range corresponds to free fractions of 10~5 to 45% 
under linear elution conditions. The slopes obtained were 
then plotted vs. load, as shown in Figure 19. The resulting 
curve showed an essentially linear increase in the measured 
slope for loads of 24% or less but with some curvature 
beginning to appear as the load increased further. 
The data in Figure 19 were used to test the extrapolation 
procedure by performing linear least-square fits over various 
load regions of the plot. The intercept obtained (i.e., the 
extrapolated value of the slope at 0% load) was then compared 
Figure 19. The effect of increasing load on the measured 
split-peak slope for a system with irreversible 
adsorption-limited kinetics. The slope values 
were determined as described in the text. The 
line shown is the linear fit to the data over the 
load range of 4 to 16% 
Measured Slope 
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to the value predicted under linear conditions, a true split-
peak slope of 1.0000 according to Equation 45. The results 
obtained are summarized in Table IX. In general, the use of 
small loads in the extrapolation gave more accurate results 
than when larger loads were used, with an error of only 0.9 
ppt being obtained with loads of 4 to 16%. However, even with 
the largest load range studied, 16 to 64%, the error was still 
less than the best experimental precision obtained with such 
measurements in the previous chapter, a value of + 3.4%. 
Figure 20 shows plots obtained when this extrapolation 
method was applied to various protein A columns using data 
from Figure 7, taken under approximately the same free 
fraction conditions used to generate the simulation results. 
The plots given represent the two matrixes shown earlier to be 
adsorption-limited, the CDI-500 and SB-50 protein A columns, 
and one in which both adsorption and diffusion contributed to 
the overall rate of IgG retention, the SB-500 protein A. Also 
shown are the simulation results for the load range of 4 to 
16%. 
In Figure 20, each protein A support gave the same linear 
response between the measured slope and load seen with the 
simulation results. This demonstrates the apparent 
applicability of this extrapolation method to complex as well 
as simple adsorption-controlled systems and, in the case of 
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Table IX. Error of linear extrapolation vs. load range for a 
system with irreversible adsorption-limited 
kinetics 
Linear least-squares fit parameters 
Load range* Slope x 103 Intercept % Error^ 
4 to 16% 3.62 + 0.03 0.9991 ± 0.0003 -0.09 
8 to 32% 3.87 ± 0.06 0.996 + 0.001 -0.4 
16 to 64% 4.43 + 0.15 0.983 + 0.007 -1.7 
&The results for each data set are for 4 points distrib­
uted evenly throughout the load range studied. 
^Calculated using the intercepts and an expected value 
under linear conditions of 1.0000. 
Figure 20. The effect of varying load on the measured split-
peak slopes for IgG on various protein A 
matrices. The protein A data are from Figure 7. 
The plots shown are for the SB-50 (A)» SB-500 
(^), and CDI-500 (#) matrices described earlier 
and the simulation results for the load range of 4 
to 16% (•) from Figure 19 
Measured Slope/Extrapolated Slope 
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the SB-500, even to those systems with some diffusional con­
tribution to their kinetics. Although the reason for the 
linearity of the SB-500 response is not totally clear, it may 
indicate that as the transition from a simple diffusion-
limited system to an adsorption-limited systems occurs, the 
increased sensitivity of the intermediate systems vs. the 
diffusion-limited case to column overloading may give them a 
response more closely resembling that of an adsorption-limited 
system. 
Another observation made in Figure 20 was that the 
experimental data showed a much larger relative increase in 
slope with load than predicted from the computer modeling. 
For example, the slope of such a plot predicted from the 
simulations was 3.62 x 10"^ for the given loads while 
experimentally this value ranged'from 0.043 to 1.18. This 
may, again, be a sign that secondary effects such as site 
heterogeneity or reversible binding were present. 
Of these, site heterogeneity may have been particularly 
important. For adsorption-limited kinetics, this may be a 
result of both diffusional, or mass transfer, heterogeneity 
and heterogeneity of the ligand. The differences in mass 
transfer heterogeneity for the two matrix materials used in 
Figure 20 has already been discussed. The possible presence 
of ligand heterogeneity in these systems was also suggested 
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earlier in that the Schiff base and GDI coupling methods 
were shown in Section I to give immobilized protein A with 
different apparent adsorption rate constants, with the Schiff 
base protein A having a kg value ten times that produced by 
the GDI method. One possible interpretation given for this 
was that the GDI method denatured the protein to a greater 
extent, producing a more heterogeneous population of ligand 
and lowering the apparent value of kg. 
Based on both types of site heterogeneity, it is possible 
to predict the same order of deviations as seen in Figure 20. 
For example, the SB-50 support, with the largest adsorption 
rate constant and the smallest amount of mass transfer hetero­
geneity, would have been expected to most closely resemble the 
simple adsorption-limited case. The SB-500 data, obtained 
using the same type of protein A but on a more porous matrix, 
would have been predicted to give larger deviations. Lastly, 
the GDI-500 results, acquired on the same matrix material as 
the SB-500 but with possibly more heterogeneous protein A, 
would have been expected to give the largest deviations. 
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CONCLUSIONS 
The simulation results presented show that nonlinear 
elution effects in split-peak chromatography can be minimized 
by using the proper separation conditions or extrapolation 
techniques. For the diffusion-limited case, it was found that 
these effects could be reduced or even eliminated by using 
small sample loads and/or fast flowrates. An expression was 
derived to calculate the flowrate and load conditions needed 
to produce nonlinear effects for the simple kinetic system 
studied. Although such a calculation is accurate for an 
experimental system only if its kinetics follow the model used 
here, this expression should still be useful for more complex 
diffusion-limited systems as a guideline in determining the 
approximate range of load or flowrate conditions that can be 
used without producing nonlinear effects. 
For the adsorption-limited case, simulations demonstrated 
that nonlinear effects can not be totally eliminated by 
changing the flowrate or load. However, the data did show 
that such effects can be minimized by using extrapolation 
techniques. This was done by making a plot of the measured 
split-peak slope vs. sample load and performing a linear fit 
to determine the slope at zero sample load. When using loads 
less than 16%, the extrapolated slope obtained for the case 
studied varied by less than 1 ppt from that expected under 
182 
linear elution conditions. Although the error increased with 
the loads used, even over a load range of 16 to 64% its level 
was still acceptable, having a value of less than 2%. 
The difference in nonlinear effects seen with the split-
peak plots obtained for these two cases suggests that such 
plots may be useful tools in determining the rate-limiting 
step for solute retention in chromatographic systems. For 
example, the split-peak plots for hemoglobin on a C8 reversed-
phase column showed the same nonlinear effects as the 
diffusion-limited case, while a similar study for IgG on a 
GDI protein A column gave results resembling those obtained 
for the adsorption-limited case. These results confirmed 
those of earlier experiments suggesting that the hemoglobin 
and IgG systems studied were diffusion- and adsorption-
limited, respectively. Thus, by making split-peak plots at 
various loads and comparing the resulting curves to the 
simulation results presented here, it may be possible to 
determine the rate-limiting step in adsorption for a given 
matrix. This should not only be useful in obtaining kinetic 
data but also in the optimization of chromatographic 
separat ions. 
Although the hemoglobin and IgG studies showed the same 
general responses predicted by the simulations, they also gave 
larger deviations than expected from the computer modeling. 
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It was proposed that this was due to the presence of secondary 
effects such as site heterogeneity or reversible binding. Of 
these, site heterogeneity may be particularly important since 
the relative size of deviations seen with various protein A 
columns was noted to follow the order predicted based on only 
their ligand and mass transfer heterogeneities. Mass transfer 
heterogeneity was also implicated in the hemoglobin study. 
Further computer modeling needs to be done to better determine 
the influence of this and other such phenomenon on the non­
linear elution effects seen in split-peak chromatography. 
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GENERAL SUMMARY AND CONCLUSION 
Summary of Experimental Results and Conclusions 
Throughout this work, a number of different aspects of 
the split-peak effect have been considered. First, previous 
observations of this phenomenon were discussed as well as the 
relative importance of this effect in affinity separations. 
Equations were then derived to describe the split-peak effect 
in terms of the kinetic processes occurring within the column. 
These processes included diffusion of the analyte between the 
flowing and stagnant mobile phases and binding of the analyte 
with the immobilized ligand. Following this, it was demon­
strated how these equations agreed qualitatively with previous 
experimental observations. 
To quantitatively test the equations developed, the 
adsorption of IgG on protein A affinity columns was used. The 
results of this study were presented in Section I. For each 
column tested, the linear relationship predicted by the model 
was noted. The data from these plots were used to measure 
kinetic parameters for the binding of IgG to immobilized 
protein A. By comparing protein A columns prepared using 
different immobilization methods and support materials, it was 
found that diffusion was rate-limiting in some cases while 
adsorption was rate-limiting in others. It was also found 
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that the apparent adsorption rate constant for the IgG-protein 
A system varied by an order of magnitude depending on which 
immobilization method was used. This indicated that the 
kinetic properties of immobilized protein A could be affected 
by the coupling method used to prepare it. 
The same model was used in Section II to optimize analyte 
adsorption in a high-performance affinity chromatographic 
system. This system consisted of two columns in series: the 
first containing immobilized anti-albumin antibodies and the 
second containing immobilized protein A. These were used for 
the analysis of HSA and IgG, respectively. In optimizing 
analyte adsorption at a given flowrate, the column size 
required by the antibody column was found to be limited by its 
binding capacity for HSA, while the protein A column was 
limited by the rate of immunoglobulin adsorption. Based on 
this and other information about the supports, a method was 
developed for the determination of both HSA and IgG in serum. 
This technique gave results in good agreement with those 
obtained with commercially available methods, while requiring 
only 2 pL of serum and 6.0 min per cycle. It was shown that 
both HSA and IgG were selectively retained by the system, with 
little interference from other serum components. 
The last study examined the effect of nonlinear elution 
conditions on the relative size of the nonretained peak. 
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This was of interest since it was noted in the previous 
studies that the relative size of the nonretained peak varied 
with sample size for IgG adsorption on protein A columns. 
This was studied using computer simulations. Two different 
cases were examined: those in which either diffusion or 
adsorption was the rate-limiting step in analyte retention. 
The simulation data were compared to results obtained for the 
adsorption of hemoglobin on reversed-phase columns and the 
binding of immunoglobulin G to protein A columns. The 
hemoglobin results were similar to those obtained with 
simulations for the diffusion-limited case, while the IgG 
results resembled those seen with the adsorption-limited case. 
From the simulations, guidelines were developed for minimizing 
or eliminating nonlinear elution effects for both of the cases 
studied. For the diffusion-limited case, it was found that 
these effects could be reduced or even eliminated through the 
use of high flowrates and/or small sample loads. In the 
adsorption-limited case, it was shown that nonlinear effects 
could not be totally eliminated by merely adjusting the 
experimental conditions. However, it was also found that 
these effects could be minimized through the use of extrapola­
tion techniques. The particular technique tested was one in 
which plots of the split-peak slope vs. sample size were made 
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and linear regression was used to extrapolate to the split-
peak slope at zero sample size. 
Over the course of these studies, a number of potential 
applications were discussed regarding the equations developed. 
One was the evaluation of the adsorption kinetics of affinity 
chromatographic supports. This was illustrated in Section I, 
where plots were prepared for various protein A supports 
according to Equation 26 and the slopes of these plots deter­
mined. Since the slope of this equation is related to the 
rate constants of the system, this parameter was used to 
compare the kinetic properties of the supports. Under given 
operating conditions, it was found that the SB-50 support 
gave the smallest slope and the fastest rate of analyte 
adsorption. The CDI-500 support, with the largest slope, had 
the slowest rate of adsorption. 
This type of information is useful in choosing which 
affinity support to use for a particular separation. Although 
the kinetic properties of a support are not normally examined 
in the design and use of affinity systems, the results 
presented here suggest this can be an important consideration. 
This is especially true for protein A supports, which were 
shown to vary in their kinetic properties depending on the 
immobilization method and packing material used to prepare 
them. The method presented here is a potentially fast and 
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easy approach for evaluating such properties, allowing 
supports to be compared simply on the basis of the size of 
their split-peak slopes. 
An application closely related to this is the optimi­
zation of analyte adsorption. This was discussed in Section 
II, where it was used in the design of a dual-column system 
for the determination of HSA and IgG in serum. In this case, 
a modified version of Equation 26 was used. This described 
the kinetic properties of a support in terms of a single 
constant independent of both the flowrate and column volume. 
Using data obtained with the protein A and anti-HSA supports, 
it was demonstrated how this constant could be used to 
calculate the minimum column residence time required to 
produce a given degree of analyte adsorption. 
This method differs from that presented by Roy et al. 
(37) in that it is a fundamental approach, relating analyte 
adsorption directly to the kinetic processes within the 
column, whereas the earlier technique was entirely empirical 
in nature. This not only gives this method a better theoret­
ical basis but also makes it more convenient to use. This is 
true since this technique makes use of a single constant to 
characterize a system rather than a series of graphs, as used 
in the earlier method. Also, once this constant has been 
determined for a support, it can be used to calculate the 
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flowrate conditions neede on any size column or the column 
size needed at any particular flowrate to give the desired 
degree of retention. The technique developed by Roy et al., 
on the other hand, requires that a series of separate reten­
tion studies be done for each column size and flowrate used. 
The expressions developed in this work should also be 
useful in studying the kinetics of chromatographic inter­
actions. One aspect of this was discussed in Section I, where 
it was suggested that they might be used to improve the per­
formance of chromatographic supports. For example, if and 
Vg for a system are known in addition to its split-peak slope, 
then it can be determined whether adsorption or diffusion is 
the rate-limiting step in retention. This was illustrated 
with the protein A supports in Section I. Once the rate-
limiting step is known, it is possible to take steps to 
improve the kinetics of the system. If diffusion is found to 
be rate-limiting, it was suggested that this might be done by 
using a packing material with a smaller particle diameter, 
increasing ki and k_i and providing faster mass transfer. 
This can also be accomplished by going from porous supports to 
pellicular or nonporous supports, as indicated by the 
reversed-phase results in Section I. If adsorption is rate-
limiting, it was suggested that the kinetics might be improved 
by using a higher ligand coverage. 
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The use of this model in studying chromatographic 
interactions is also of interest from a fundamental point-of-
view. One example of this was given in Section I. In this 
experiment, the split-peak slopes of the protein A supports 
were combined with other chromatographic parameters to 
determine the value of kg for each support. This provided a 
means of studying the effect of using different immobilization 
methods on the kinetic properties of the resulting ligand. 
The equations developed in this work have also been used to 
examine the retention of proteins on reversed-phase columns 
(121). In this case, the experimental change in k^ with the 
particle diameter and the diffusion coefficient was found to 
be the same as that predicted by Equation 31, indicating the 
system was indeed diffusion-limited (121). Both examples 
demonstrate the potential usefulness of this approach in 
examining the kinetics of analyte-ligand interactions and 
other chromatographic processes. 
Suggestions for Further Research 
All of the applications dealt with in the preceding 
discussion involved using the equations and model developed to 
study the kinetic properties of chromatographic systems. 
These applications included comparing the kinetic properties 
of affinity supports, designing more efficient chromatographic 
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supports, and optimizing analyte adsorption on affinity-
columns or matrices. Another area in which these equations 
might be useful is in the determination of rate constants for 
macromolecular interactions. Possible advantages of using 
split-peak measurements for this were discussed in Section I. 
To use this approach for such determinations, it is first 
necessary to determine how the values of kg obtained with this 
method compare to those measured with other techniques. This 
requires that some model system be tested for which rate 
constants and equilibrium data are already available. Two 
systems that have already been proposed for such studies are 
the binding of dinitrophenyl (DNP) haptens with immobilized 
MOPC 315 antibodies and the binding of p-nitrophenyl a-D-
mannopyranoside (PNPM) with immobilized concanavalin A (125). 
Both are well-characterized systems with known equilibrium and 
rate constants. For example, the interation of DNP-NH-CH3 
haptens with MOPC 315 has an adsorption rate constant of 
5.2 X 10® M~^ s"^ and an equilibrium binding constant of 
9.6 X 10^ M~^ (128). The binding of PNPM with concanavalin A 
has a value for kg of 5.4 x 10^ M~^ s~^ and a value for K3 of 
8.7 X 10^ M"^ (129). 
In preliminary calculations, it was shown that neither of 
these systems is suitable for the split-peak determination of 
adsorption rate constants (125). This was discovered when the 
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various experimental factors needed to obtain sufficient 
separation of the nonretained and retained peak (i.e., a k'2 
10) and adsorption-limited conditions (i.e., l/kg mL > 
1/ki Ve) were considered. For the DNP-antibody system, it was 
shown that adsorption is too fast to allow kg to be accurately 
measured under reasonable operating conditions. In the PNPM-
concanavalin A system, it was found that adsorption-limited 
conditions were more easily achieved, however, the column size 
required for this was too small to be experimentally useful. 
Other calculations showed that all necessary experimental 
requirements might best be met by using reactions with rate 
and equilibrium constants similar to those of the IgG-protein 
A system (125). One general class of reactions that fits this 
description is the binding of macromolecular antigens with 
antibodies. 
A review of the literature reveals that there at least 
two such systems available for study. One is the binding of 
staphylococcal nuclease with anti-nuclease antibodies (130) 
and the other is the binding of hemoglobin S with anti-
hemoglobin S antibodies (131). The first has been reported to 
have an adsorption rate constant of 4.1 x 10^ M~^ s and a 
equilibrium binding constant of 8,3 x 10® (130). The 
second system has been reported to have a kg of 5.8 x 105 
s~^ and a Kg of 2.1 x 10^® (131). Note that both systems 
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have rate and equilibrium constants comparable to those 
believed to describe the IgG-protein A system. 
Another system which might be used is the interaction of 
various steroids with glucocorticoid receptors. In this case, 
the rate and equilibrium constants are available for the 
binding of at least 7 different steroids to the hormone 
receptor. For this series of reactions, kg has been shown to 
have values ranging from 2.3 x 10^ to 2.6 x 10^ M~^ s~^ and 
K3 has been found to have typical values of 1.2 x 10^ to 
3.2 X 10^ (132). Again, these are approximately the same 
order of magnitude as the constants believed to be present in 
the IgG-protein A system. 
In using these systems for split-peak measurements, it is 
first necessary to prepare a support containing a ligand 
representing one of the molecules in the reaction of interest. 
This support can be prepared by using the immobilization 
methods already discussed or through a number of related 
techniques (5,29). As in the case of protein A, the kinetic 
properties of the ligand may be susceptible to the 
immobilization method used. Thus, steps should be taken to 
allow for this. One way in which this might be done is by 
comparing the rate constants obtained on supports prepared by 
different immobilization methods. This is the same technique 
used in Section I. Another approach would be to compare the 
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results obtained on a set of columns using different molecules 
from the system of interest as the affinity ligand. It is 
particularly important to take such precautions with the 
antibody-antigen systems described, due to the relative 
susceptability of proteins to immobilization effects (29,90). 
This may be less of a problem when using the glucocorticoid 
receptor system, since in this case a steroid can be used as 
the affinity ligand. 
Once the support has been prepared and the conditions 
required to adsorb and elute analyte are known, split-peak 
measurements can be made. It should be possible to do this 
by using standard chromatographic detectors, monitoring 
absorbance at 280 or 254 nm. The adsorption rate for the 
system can be obtained by making making split-peak 
measurements at various flowrates and plotting the data 
according to Equation 26. From the slope of these plots and 
independent estimates of m^, k%, and Vg, it is possible to 
calculate kg. In performing this experiment, it is advised 
that an estimate of the diffusional term of the slope first be 
obtained, using the methods described in Section I. This is 
to insure that adsorption-limited conditions are present when 
these measurements are made. It is also necessary to correct 
the results for nonlinear elution effects. This can be done 
by using the extrapolation technique described in Section III. 
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To properly correct for nonlinear elution conditions in 
such studies, further work needs to be done in examining the 
role of secondary effects on split-peak measurements. Of 
these effects, heterogeneity is particularly of interest. One 
reason for this is that heterogeneity was implicated in both 
the reversed-phase and affinity studies in Section III as a 
major reason for the differences between the experimental and 
simulation results. Heterogeneity is also of interest since 
it was noted in the protein A studies that the sample-size 
dependence of the split-peak slope appeared to be directly 
related to this effect. If this is true, then the split-peak 
effect might be useful in evaluating the heterogeneity of 
affinity columns. 
To examine the role of heterogeneity more closely, a 
series of simulations can be performed similar to those 
presented in Section III. The models used for this must 
consider the effect of having at least two types of 
kinetically distinct ligands present along with either 
adsorption- or diffusion-limited kinetics. For the diffusion-
limited case, such a system may be represented by the 
following reactions: 
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E. (60) P 
Fast 
» Ep-L (61) 
Fast 
+ L' » E^ -L- ( 6 2 )  
These reactions describe mass transfer of E from the flowing 
mobile phase to two diffusionally-distinct regions in the 
column. These regions can be thought of as representing the 
surface of particles with different diameters or different 
parts of the same support, such as the area within its pores 
and on its surface. Mass transfer of analyte to these regions 
is described by the rate constants ki/k_i and respec­
tively. The ligands located at each type of site are referred 
to as L and L*. Although these ligands are both assumed to 
have infinitely fast adsorption kinetics, they are distin­
guished from each other since the relative amount of ligand 
occuring in each region may vary. 
Simulations may be performed for this system by using the 
computer model presented in Section III and a series of 
equations describing the change in Eg, Ep, Ep , L, and L' as a 
function of time. Such equations can be developed based on 
the work of Rakowski (133), allowing the effect of varying 
ki/k_i, k^/k^i , and m^ym^ to be determined. 
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The effect of heterogeneity in diffusion-limited systems 
may be studied experimentally by using the adsorption of 
hemoglobin on reversed-phase columns, the same system used in 
Section III. To examine this effect, it is proposed that 
split-peak measurements for hemoglobin be made on at least two 
columns, each containing a nonporous support of a different 
diameter. Assuming the supports have fairly uniform particle 
diameters, these columns should represent reasonably homoge­
neous systems. From split-peak measurements on these columns 
and independent estimates of Vg, the value of ki for each 
support can be determined. Since supports with different 
diameters are used. Equation 31 predicts that different values 
of ki should be obtained for each column. 
Following these measurements, it is suggested that a 
series of split-peak studies on mixed-bed columns also be 
done. These columns can be prepared by combining any two of 
the previously studied supports. The result should be a 
controlled heterogeneous system. By varying the relative 
amount of each support added, the amounts of L and L* can be 
changed. The value of k^/k_^ and k^/k^^ can be adjusted by 
varying the particle diameter of the supports. A series of 
hemoglobin split-peak studies on such columns, then, should be 
useful in generating experimental data to compare to the 
simulation results. 
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A similar set of studies can be performed examining the 
effect of heterogeneity in the adsorption-limited case. The 
model proposed for these studies is represented by the fol­
lowing reactions: 
Kl 
Ee , Ep ( 6 3 )  
k3 
E p  +  L  >  E p - L  ( 6 4 )  
Ep + L' > Ep-L' (65) 
As in the simple adsorption-limited model used in Section III, 
these reactions assume that the free analyte is in equilibrium 
between the flowing and stagnant mobile phases. Unlike the 
model in Section III, however, the analyte can bind with two 
types of ligand sites in the stagnant mobile phase, each with 
its own kinetic properties. 
Equations can also be developed to allow this system to 
be studied with the computer model. This can be done 
based on an approach similar to that used in Section III for 
the simple adsorption-limited case, giving expressions which 
describe analyte retention as a function of time and such 
parameters as K^, kg, k^» the porosities of the support, and 
the relative amount of each ligand present. By using these 
equations with the computer model, simulations can be per­
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formed to examine the effect of changing each of these 
variables on the relative size of the nonretained peak. 
This system can be studied experimentally by examining 
the retention of glucocorticoid receptor on immobilized 
steroid columns. In these studies, it is proposed that split-
peak measurements for the hormone receptor be made on at least 
two different steroid columns. These columns should contain 
nonporous supports made up of identical packing material but 
different immobilized steroids. Nonporous supports are used 
to minimize diffusional heterogeneity and to help produce 
adsorption-limited conditions. Using split-peak studies on 
these supports, the value of kg for each support can be 
determined. By using different steroids as the ligands, 
different values of k3 should be obtained, a possible range of 
2.3 X 10^ to 2.6 X 10^ s"^ (132). 
Following these measurements, a series of split-peak 
measurements on mixed-bed columns can also be done. These 
columns can be prepared as described earlier by combining 
various amounts of the previously studied supports. The 
amount of L and L* in these columns can be varied by changing 
the relative amount of each support added. The values of kg 
and k^ can be altered by using supports with different 
immobilized steroids. Again, the result is a controlled 
heterogeneous system. By adjusting these various parameters 
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and making split-peak measurements with the glucocorticoid 
receptor, experimental data can be obtained to compare to the 
simulation results. 
In addition to these experiments, a number of other 
studies are also possible. These include an examination 
of the effect of reversible binding on split-peak measure­
ments under nonlinear elution conditions, determination of the 
reasons behind the immobilization-dependence of protein A 
kinetics, and the use of the split-peak effect in the 
optimization or study of other affinity systems. Regardless 
of the work which remains, it is clear from the results 
presented that the split-peak effect can be a useful 
chromatographic tool. Because of this, it is predicted that 
the future will bring an increased use of this effect in the 
study and design of biomacromolecular separations. 
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APPENDIX 
The following pages contain listings of the programs used 
in the simulations presented in Section III. The first 
program is that which was used to examine the diffusion-
limited case. The second is that which was used in the 
adsorption-limited studies. Both are similar In their overall 
design. Definitions of the variables used in these programs 
are included in the listings as well as simple explanations of 
how the programs operate. 
212 
C *****«**«*«***•*•*******•********•***•**«•«**«**«•********«*** 
C * * 
C * SIMULATION PROGRAM FOR THE CASE OF * 
C * DIFFUSION-LIMITED KINETICS WITH * 
C * IRREVERSIBLE ADSORPTION * 
C * * 
C A * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
C 
C 
c ******************pjvraheter initialization******************** 
C 
c c(x,?) - the simulated column where x is the slice 
C NUMBER AND 7 IS THE PHASE (7 « 1, 2, AND 3 
C FOR THE FLOWING MOBILE PHASE, STAGNANT 
C MOBILE PHASE, AND STATIONARY PHASE) 
C A(X,7) - A STORAGE ARRAY TO ALLOW THE ANALYTE 
C ELUTING FROM THE COLUMN DURING ANY 
C ITERATION TO BE DISPLAYED, WHERE X - THE 
C ITERATION NUMBER AND 7 IS THE PHASE, AS 
C ABOVE 
C LNGTH - THE TOTAL COLUMN LENGTH + 1 
C MONTR(X) - THE SLICE ON THE COLUMN MONITORED FOR 
C AMAL7TE ELUTION 
C INCRM(X) - THE ITERATION STEP SIZE AT WHICH THE 
C ANAL7TE ELUTION DATA IS TO BE PRINTED 
C OUT FOR THE MONITORED SLICE MONTR(X) 
C RK1,RK2 - K1 AND K-1 
C VE,VP - VE AND VP 
C G1,G2 - VB/VM AND VP/VM 
C E1,EQ1 - e-(Kl + K-1) AND 1 - e(-Kl) 
C NM - THE NUMBER OF SLICES MONITORED 
C E3 - THE TOTAL AMOUNT OF ANAL7TE APPLIED 
C E2 - THE TOTAL FRACTION OF FREE ANAL7TE ELUTED 
C WHEN THE PROGRAM IS TERMINATED 
C IMAX - THE MAXIMUM NUMBER OF ITERATIONS ALLOWED 
C 
C THE REMAINDER OF THE VARIABLES ARE TEMP0RAR7 STORAGE OR 
C CALCULATION BUFFERS 
C 
C 
DIMENSION 1NCRM(8),M0NTR(8) 
REAL*8 C(2562,3),A(20000,5),CT,D,RK1,RK2,VE,VP,G1,G2,E1,E2,E3, 
XEQ1,TF,SUM,SMF,CA,FF,D2 
LNGTH-401 
VE-1. 
VP-1.0 
RKl-0.050 
RK2-RK1*VE/VP 
G1-VE/(VE+VP> 
G2-VP/(VE+VP) 
E1-DEXP(-RK1-RK2) 
EQ1=1.-DEXP(-RK1) 
NM-4 
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MONTR(l).(LNGTH-l) 
MONTR(2)-(LNGTH-1)/2 
MONTR(3 >-(LNGTH-1)/4 
MONTR(4)-MONTR(3)+20 
MONTR(5)-MONTR(3)-20 
MONTR(6)-(LNGTH-1)/32 
MONTR(7)-(LNGTH-1)/G4 
MONTR(8)-(LNGTH-1)/128 
INCRM(1)-100 
INCRM(2)-100 
INCRM(3)-100 
INCRM(4)-100 
INCRM(5)«100 
INCRM(6)-100 
INCRM(7)-50 
INCRM(8)-50 
WRITE (9,10) 
10 FORMAT (/,/,/,/,/,5X, 
X'CASE - DIFPUSION-LIMITED/SINGLE SITE-SINGLE ANALÏTE') 
C 
C «***********«*«***«*siMULATION PROCEDURES******************** 
C 
C THE SIMULATION IS CARRIED OUT WITHIN THREE NESTED LOOPS 
C ORGANIZED AS FOLLOWS: 
C 
C LDCNT LOOP (VARIES LOAD APPLIED) 
C 
C IL LOOP (VARIES TIME SINCE INJECTION) 
C 
C K LOOP (VARIES SLICE EXAMINED) 
C 
C KINETIC EQUATIONS FOR THE CASE 
C STUDIED FOR ANALYTE DISTIBUTION 
C 
C CONTINUE K LOOP (LINE 60) 
C 
C CONTINUE IL LOOP (LINE 150) 
C 
C CONTINUE LDCNT LOOP (LINE 400) 
C 
C ************************************************************ 
c 
DO 400 LDCNT-1,1 
C(1,1)-0.24*FLOAT(LNGTH-1)/(2.**FL0AT(LDCNT-1)) 
E2-0.999999 
E3-C(l,l) 
C(l,2)-0. 
C(l,3)-0. 
FF-0. 
SUM-0. 
IMAX-20000 
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DO 20 K«2,LNGTH 
DO 20 J-1,3 
20 C(K,J)-0. 
KS-1 
KL-1 
DO ISO IL-1,IMAX 
IF (IL.LT.LNGTH) GO TO 30 
D2»FF/(FF+SUM) 
IF (D2.GB.B2) GO TO 160 
30 SUM-0. 
DO 60 R-KS,RL 
IF (C(K,3).LT.l.) GO TO 40 
D-C(K,1)+C(K,2) 
IF (D.EQ.O.) GO TO 60 
C(K,1)-D*G1+(C(K,1)*G2-C(K,2)*G1)*E1 
C(K,2)»D-C(K,1) 
GO TO 60 
40 D-C(K,3)+EQ1*C(K,1) 
IF (D.GT.l.) GO TO 50 
C(K,3)>D 
C(K,1)»C(K,1)*(1.-EQ1) 
GO TO 60 
50 TF--DL0G((C(K,3)+C(K,1)-1.)/C(K,1))/RKl 
C(K,1)-C(K,1)-1.+C(K,3) 
C(K,3)»1. 
D-C(K,1)+C(K,2) 
IF (D.EQ.O.) GO TO 60 
C(K,1)«D*G1+(C(K,1)*G2-C(K,2)*G1)*DEXP((TF-1.)*(RK1+RK2)) 
C(K,2)«D-C(K,1) 
60 CONTINUE 
R-KL 
70 C(K+1,1)-C(K,1) 
IF (K.LT.LNGTH) SUM-SUM+C(X+1,1)+C(K+1,2) 
K-K-1 
IF (K.GE.KS) GO TO 70 
C(KS,l)-0. 
SUM-SUM+C(KS,2) 
KL-KL+1 
IF (KL.GT.LNGTM) KL-LNGTH 
D»C(KS,1)+C(KS,2) 
IF (D.EQ.O.) KS-KS+1 
DO 80 MQ-1,NM 
80 A(IL,MQ)-C(M0NTR(MQ)+1,1) 
FF-FF+A(IL,1) 
150 CONTINUE 
160 IMAX-IL 
DO 300 MQ-1,NM 
CT-A(MONTR(MQ),MQ) 
IMIN-M0NTR(MQ)+1 
DO 170 I-IMIN,IMAX 
170 CT-CT+A(I,MQ) 
IF (MQ.NE.l) GO TO 220 
215 
O-O. 
TF-0. 
CT-CT/E3 
KZ-LNGTH-1 
DO 180 K-1,KZ 
D-D+C(K,3)/B3 
180 TF-TF+(C{K,1)+C(K,2))/E3 
SUM-D+TF+CT 
SMF-CT/(CT+TF) 
C 
c out of simulation results************** 
c 
WRITE (9,190) 
190 FORMAT (/,/, 
X'************************************************************ 
X/,/,14X,'ANALYTE FRACTIONAL DISTRIBUTION') 
WRITE (9,200) D,TF,CT,SUM,SMF 
200 FORMAT  ( / , 2 X , ' A D S O R B E D 2 X , *  F R E E  O N  C O L 2 X E L U T E D 2 X ,  
X'TOTAL RECOVERED',2X,'FRAC FR ELUTED',IX,DIO.5,IX, 
XD10.5,1X,D10.5,2X,D12.7,4X,D12.7) 
CA-FLOAT(IMAX)/FLOAT(MONTR(1)) 
WRITE (9,210) 1MAX,M0NTR(1),CA 
210 FORMAT {/,20X,'ITERATION STATISTICS',/,/,IIX,'ITERATIONS',2X, 
X'MAX LENGTH',2X,'ITER/MAX LENGTH',/, 
X13X,I5,7X,I5,7X,D10.5) 
220 WRITE (9,230) RK1,RK2,VE,VP,MONTR(MQ) 
230 FORMAT (/,/,/,/,/,12X,'Kl',9X,'K2',6X,'VE',4X,'VP',4X, 
X'UE',2X,'LENGTH',/,8X,D9.4,2X,D9.4,2X,F4.2,2X,F4.2,2X, 
X'1.0',3X,I4) 
D-1./FLOAT(MONTR(MQ)) 
TF-D/RKl 
SUM-E3/FL0AT(MONTR(MQ)) 
E2-100.*((RK1/EQ1)-1.) 
WRITE (9,240) D,TF,SUM,E2 
240 FORMAT (/,7X,'UE/L',7X,'UE/LKl',7X,'LOAD',6X, 
X'% SIMULATION ERROR',/,4X,F10.8,2X,F10.7,1X,F10.6,6X,F10.6) 
b-DEXP(-l./TF) 
IF (MQ.NE.l) CT-CT/E3 
E2«100.*CT/D 
WRITE (9,250) D,CT,E2 
250 FORMAT (/,18X,'IDEAL',6X,'MEASURED',lOX,'% OF IDEAL',/,3X, 
X' FREE AREA',3X,D10.5,2X,D10.5,5X,F16.8) 
D—1./DL0G(CT) 
E2-100.*D/TF 
WRITE (9,260) TF,D,E2 
260 FORMAT (3X,' -1/LN F',4X,F10.6,2X,FIO.6,5X,F16.8) 
WRITE (9,270) 
270 FORMAT (/,18X,'TIME',11X,'RESPONSE',/) 
INC-INCRM(MQ) 
216 
IMIN-IMIN-1 
DO 280 I-IMIN,IMAX,INC 
IF (A(I,Mg).LT..000000001) GO TO 280 
WRITE (9,290) I,A(I,MQ) 
280 CONTINUE 
290 FORMAT (12X,I10,7X,F14.10) 
300 CONTINUE 
400 CONTINUE 
500 STOP 
END 
217 
C 
C 
C 
C 
C 
C 
C 
C 
C ***********#********pARAMETER INITIALIZATION****************** 
C 
C C(X,Y) - THE SIMULATED COLUMN WHERE X IS THE SLICE 
C NUMBER AND Y IS THE PHASE (Y - 1, 2, AND 3 
C FOR THE FLOWING MOBILE PHASE, STAGNANT 
C MOBILE PHASE, AND STATIONARY PHASE) 
C A(X,Y) - A STORAGE ARRAY TO ALLOW THE ANALYTE 
C ELUTING FROM THE COLUMN DURINNG ANY 
C ITERATION TO BE DISPLAYED, WHERE X « THE 
C ITERATION NUMBER AND Y IS THE PHASE, AS 
C ABOVE 
C LNGTH - THE TOTAL COLUMN LENGTH + 1 
C MONTR(X) - THE SLICE ON THE COLUMN MONITORED FOR 
C INCRM(X) - THE ITERATION STEP SIZE AT WHICH THE 
C ANALYTE ELUTION DATA IS TO BE PRINTED 
C OUT FOR THE MONITORED SLICE MONTR(X) 
C VE,VP - VE AND VP 
C G2 - VE/VP 
C G3,G6 - VP/VM AND VE/VM 
C R1 - K3/VM 
C G1 - K3 L/VM 
C HM - THE NUMBER OF SLICES MONITORED 
C E3 - THE TOTAL AMOUNT OF ANALYTE APPLIED 
C E2 > THE TOTAL FRACTION OF FREE ANALYTE ELUTED 
C WHEN THE PROGRAM IS TERMINATED 
C I MAX - THE MAXIMUM NUMBER OF ITERATIONS ALLOWED 
C G5 " OVERFLOW MONITOR FOR LOG CALCULATIONS 
C G8,G9 - MONITORS TO COMPARE mLso TO (mEpso + mEeso) 
C 
C ************************************************************** 
C 
DIMENSION INCRM(11),M0NTR(11) 
REAL*8 C(2562,3),A(5000,11),CT,D,VE,VP,G1,G2,G3,G4,G5,G6,E2,E3 
XG7,G8,G9,CC0,CC1,X1,X2,TF,SUM,SMF,CA,FF,D2,T,TM,R1 
LNGTH-257 
VE-1. 
VP-1.0 
R1-(1./2.)/(64.**2) 
G1"R1*DFL0AT(LNGTH-1) 
G2-VE/VP 
G3«VP/(VE+VP) 
G6-VE/(VE+VP) 
G5-87.498233534 
G8-0.999999999 
G9-2.000000000-G8 
NM-1 
SIMULATION PROGRAM FOR THE CASE OF 
IRREVERSIBLE ADSORPTION-LIMITED KINETICS 
218 
m0ntr(1)-(lngth-1) 
MONTR(2)-(LNGTH-l)/2 
MONTR(3)-(LNGTH-1)/4 
MONTR(4)-(LNGTH-1)/8 
MONTR(5)-(LNGTH-1)/16 
MONTR(6)-(LNGTH-1)/32 
M0NTR(7)-(M0NTR(2))+128 
MONTR(8)-(MONTR(3)+64) 
MONTR(9)-MONTR(4)+32 
MONTR(10)"MONTR(5)+16 
MONTR(11)"MONTR(6)+8 
INCRM(1)-100 
INCRM(2)-100 
INCRM(3)-100 
INCRM(4)-100 
INCRM(5)-100 
INCRM(6)-100 
INCRM(7)-100 
1NCRM(8)-100 
1NCRM(9)-100 
INCRM(10)>100 
INCRM(11)"100 
WRITE (9,10) 
10 format (/,/,/,/,/,SX, 
X'CASE - ADSORPTION-LIMITED/SINGLE SITE-SINGLE ANALYTE') 
C 
C ********************siMULATION PROCEDURES*************#******* 
C 
C THE SIMULATION IS CARRIED OUT WITHIN THREE NESTED LOOPS 
C ORGANIZED AS FOLLOWS: 
C 
C LDNCT LOOP (VARIES LOAD APPLIED) 
C 
C IL LOOP (VARIES TIME SINCE INJECTION) 
C 
C K LOOP (VARIES SLICE EXAMINED) 
C 
C KINETICS EQUATIONS FOR THE CASE 
C STUDIED FOR AMAL7TE DISTRIBUTION 
C 
c continue k loop (line 120) 
C 
C CONTINUE IL LOOP (LINE 150) 
c 
C CONTINUE LDCNT LOOP (LIE 400) 
C 
C ************************************************************** 
c 
do 400 ldcnt-1,1 
C(1,1)-0.16*DFL0AT(LNGTH-1)*(1+DFLOAT(LDCNT-1)*2) 
E2-0.999999 
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K3-C(l,l) 
C(l,2)-0. 
C(l,3)-0. 
FF-0. 
SUM-0. 
IMAX-20000 
00 20 R*2,LNGTH 
DO 20 J.1,3 
20 C(K,J)-0. 
RS-1 
KL-1 
DO 150 IL-1,IMAX 
IF (IL.LT.LK6TH) GO TO 30 
D2-FF/(FF+SUM) 
IF (D2.GE.E2) GO TO 160 
30 SUM-0. 
DO 120 R-KS,RL 
40 CC0-1.-C(R,3) 
X2-C{R,1)+C(R,2) 
X1-X2-CC0 
IF (CCO.GT.O.) GO TO 50 
CCl-0. 
GO TO 100 
50 G7-CC0*G8 
IF (R2.LT.G7) GO TO 60 
G7-CC0*G9 
IF (X2.GT.G7) GO TO 60 
GO TO 70 
60 G4-X1*G1 
IF (G4.LT.G5) GO TO 80 
CCl-0. 
GO TO 90 
70 CC1-1/((1/CC0)+G1) 
C(R,2)-CC1*G3 
C(R,3)-C(R,3)+CC0-CC1 
GO TO 110 
80 CCl-(CCO*Xl)/((DEXP(X1*G1))*X2-CC0) 
90 C(R,3)-C(R,3)+CC0-CC1 
100 C(R,2)-(X1+CC1)*G3 
110 C(R,1)-C(R,2)*G2 
120 CONTINUE 
R-RL 
130 C(R+1,1)-C(R,1) 
IF (R.LT.LNGTH) SUM»SUM+C(K+1,1)+C(R+1,2) 
R-R-1 
IF (R.GB.RS) GO TO 130 
C(RS,l)-0. 
SUM.SUM+C(RS,2) 
RL-RL+1 
IF (RL.GT.LNGTH) RL-LNGTH 
D-C(RS,1)+C(RS,2) 
IF (D.EQ.O.) RS-RS+1 
220 
DO 140 NQ-1,NM 
140 A(IL,MO)-C(HONTR(MO)+1,1) 
FF-FF+A(IL,1) 
ISO CONTINUE 
160 IHAZ-IL 
00 300 MQ-1,NM 
CT-A(MONTR(HQ),HQ) 
IMIM-M0NTR(MQ)+1 
DO 170 I-IMIN,IMAX 
170 CT-CT+A(I,HQ) 
IF (MQ.NE.l) GO TO 220 
D-0. 
TF-0. 
CT-CT/E3 
KZ-LNGTH-1 
DO 180 K-1,KZ 
D-D+C(K,3)/E3 
180 TF-TF+(C(K,1)+C(K,2))/E3 
SUM-D+TF+CT 
SMF-CT/(CT+TF) 
C 
C OUT OF SIMULATION RESULTS**************' 
C 
WRITE (9,190) 
190 FORMAT (/,/, 
%,************************************************************' 
Z/,/,14X,'ANAL7TE FRACTIONAL DISTRIBUTION') 
WRITE (9,200) D,TF,CT,SUM,SHF 
200 FORMAT (/,2X,'ADSORBED',2X,'FREE ON COL',2X,'ELUTED',2X, 
X'TOTAL RECOVERED',2X,'FRAC PR ELUTED',/,IX,DIO.5,IX, 
XD10.5,1X,D10.5,2X,D12.7,4X,D12.7) 
CA-DFLOAT(IMAX)/DFLOAT(MONTR(1)) 
WRITE (9,210) IMAX,M0NTR(1),CA 
2 1 0  F O R M A T  ( / , 2 0 X , ' I T E R A T I O N  S T A T I S T I C S I I X , ' I T E R A T I O N S 2 X ,  
X'MAX LENGTH',2X,'ITER/MAX LENGTH 
X13X,I5,7X,I5,7X,D10.5) 
220 WRITE (9,230) Rl,G2,G3,G6,MONTR(MQ) 
230 FORMAT (/,/,/,/,/,6X,'K3/VM',8X,'VE/VP',6X,'VP/VM',5X,'VE/VM', 
X'UE',4X,'LENGTH',/,3X,D12.7,2X,D9.4,2X,D9.4,2X,D9.4,2X, 
X'1.0',3X,I4) 
D>1./DFLOAT(MONTR(MQ)) 
TF-D*D*G6/R1 
SUM-E3/DFL0AT(MONTR(MQ)) 
WRITE (9,240) D,TF,SUM 
240 FORMAT (/,7X,'UE/L',7X,'(UE/L)(K-1/K1K3(L))',7X,'LOAD', 
X/,4X,F10.8,8X,F10.7,8X,F10.6) 
d-dexp(-i./tf) 
IF (MQ.NE.l) CT-CT/E3 
E2-100.*CT/D 
WRITE (9,250) D,CT,E2 
250 FORMAT (/,18X,'IDEAL',6X,'MEASUREDlOX,'% OF IDEAL',/,3X, 
X' FREE AREA',3X,D10.5,2X,D10.5,5X,F16.8) 
D—l./DLOG(CT) 
B2-100.*D/TF 
221 
WRITE (9,260) TF,D,E2 
260 FORMAT (3X,' -1/LN F',4X,F10.6,2X,F10.6,6X,F16.8) 
WRITE (9,270) 
270 FORMAT (/,18X,'TIME*,IIX,'RESPONSE',/) 
INC=INCRM(MQ) 
imin-lmin-1 
DO 280 I-IMIN,IMAX,INC 
IF (A(I,MQ).LT..000000001) GO TO 280 
WRITE (9,290) I,A(I,MQ) 
280 CONTINUE 
290 FORMAT (12X,I10,7X,F14.10) 
300 CONTINUE 
400 CONTINUE 
500 STOP 
END 
